☐ | Preliminary Proxy Statement |
☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☒ | Definitive Proxy Statement |
☐ | Definitive Additional Materials |
☐ | Soliciting Material Pursuant to Section 240.14a-12 |
☒ | No fee required. |
☐ | Fee paid previously with preliminary materials. |
☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
| RPM INTERNATIONAL INC. 2628 PEARL ROAD MEDINA, OHIO 44256 330-273-5090 | |
| 1 | | | To adopt an amendment to the Company’s Amended and Restated Certificate of Incorporation to require the annual election of Directors; | |
| 2 | | | To elect three Directors to serve in Class II of the Board; | |
| 3 | | | To hold a non-binding, advisory vote to approve the Company’s executive compensation; | |
| 4 | | | To approve and adopt the Company’s 2024 Omnibus Equity and Incentive Plan; | |
| 5 | | | To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the current fiscal year ending May 31, 2025; and | |
| 6 | | | To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof. | |
DATE Thursday, October 3, 2024 | | | VIRTUAL MEETING Online at www.virtualshareholder meeting.com/RPM2024 | | ||
TIME 1:30 p.m., Eastern Daylight Time | | | RECORD DATE Friday, August 9, 2024 | |
| Your Vote is Important RPM INTERNATIONAL INC. 2628 PEARL ROAD MEDINA, OHIO 44256 330-273-5090 | |
| | 2024 Proxy Statement | | | 1 |
Meeting Details | | | How to Vote | | ||
DATE Thursday, October 3, 2024 | | | BY PHONE Call 1-800-690-6309 by 11:59 PM, Eastern Daylight Time, on October 2, 2024 for shares held directly or 11:59 PM, Eastern Daylight Time, on September 30, 2024 for shares held in a Plan | | ||
TIME 1:30 PM, Eastern Daylight Time | | | BY MAIL Sign, date and return your proxy card or voting instruction form by October 2, 2024 | | ||
VIRTUAL MEETING Online at www.virtualshareholder meeting.com/RPM2024 | | | BY TABLET OR SMARTPHONE Online at www.virtualshareholder meeting.com/RPM2024 | | ||
RECORD DATE Shareholders of record on the close of business on August 9, 2024 are entitled to vote at the 2024 Annual Meeting. | | | BY INTERNET Using your computer visit proxyvote.com until 11:59 PM, Eastern Daylight Time, on October 2, 2024 for shares held directly or 11:59 PM, Eastern Daylight Time, on September 30, 2024 for shares held in a Plan or vote online on October 3, 2024 during the Annual Meeting at: www.virtualshareholdermeeting.com/RPM2024 | |
| Proposals | | | Board Recommendation | | | Page | | |||
| 1 | | | To adopt an amendment to the Company’s Amended and Restated Certificate of Incorporation to require the annual election of Directors | | | FOR | | | | |
| 2 | | | To elect three Directors to serve in Class II of the Board | | | FOR each Director | | | | |
| 3 | | | To hold a non-binding, advisory vote to approve the Company’s executive compensation | | | FOR | | | | |
| 4 | | | To approve and adopt the Company’s 2024 Omnibus Equity and Incentive Plan (the “2024 Omnibus Plan”) | | | FOR | | | | |
| 5 | | | To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the current fiscal year ending May 31, 2025 | | | FOR | | | |
2 | | | 2024 Proxy Statement | | |
• | Consolidated net sales increased 1.1% to $7.34 billion in fiscal 2024 from $7.26 billion in fiscal 2023; |
• | Net income attributable to RPM International Inc. stockholders increased 22.9% to $588.4 million in fiscal 2023 from $478.7 million in fiscal 2023; |
• | Diluted earnings per share increased 22.6% to $4.56 in fiscal 2024 from $3.72 in fiscal 2023; and |
• | Cash provided by operating activities increased to $1.12 billion in fiscal 2024 from $577.1 million in fiscal 2023, with the increase driven by improved profitability and working capital efficiency, both of which were enabled by MAP 2025 initiatives. |
| | 2024 Proxy Statement | | | 3 |
| Reduce Scope 1 and Scope 2 greenhouse gas emissions from the Company’s facilities by 20% per ton of production | | | Reduce energy consumed in the Company’s facilities by 10% per ton of production | | | Identify and implement additional opportunities for water reuse and conservation, including actively evaluating and investing in the replacement of single-pass water discharge systems | |
• | Overseeing the Company’s sustainability program; |
• | Determining which ESG risks and opportunities are of strategic significance to the Company, and recommending policies, practices and disclosures relating to same to the Chief Executive Officer and the Board of Directors; |
• | Reporting to the Governance and Nominating Committee of the Board of Directors concerning ESG matters; and |
• | Developing a framework to monitor the Company’s compliance with ESG matters. |
4 | | | 2024 Proxy Statement | | |
| Board Independence | | | Ten of the eleven current Directors are independent under the Company’s Corporate Governance Guidelines and NYSE listing standards. All members of the Audit Committee, the Compensation Committee and the Governance and Nominating Committee are independent. | |
| Independent Directors Meetings | | | Independent Directors meet in executive sessions each year in January, April and July, without management present. | |
| Lead Director | | | One independent Director serves as Lead Director. | |
| Majority Voting for Directors | | | In an uncontested election, any nominee for Director who receives more votes “withheld” from his or her election than votes “for” such election is expected to tender his or her resignation for prompt consideration by the Governance and Nominating Committee and by the Board of Directors. | |
| Director Tenure | | | The average tenure of our independent Directors will be 10.8 years as of the date of the Annual Meeting, and six of our current independent Directors have joined the Board of Directors since 2015. | |
| Stock Ownership Guidelines for Directors and Executive Officers | | | The Company adopted stock ownership guidelines for Directors and executive officers in 2012, and the Company increased the stock ownership guidelines for Directors in 2014 and executive officers in 2022. Each of the Directors and executive officers satisfies the stock ownership guidelines or is within the grace period provided by the stock ownership guidelines to achieve compliance. | |
| Annual Board and Chief Executive Officer Self-Evaluations | | | Each year, the Governance and Nominating Committee of the Board of Directors administers self-evaluations of the Board of Directors and its committees, and the Compensation Committee of the Board of Directors administers an evaluation of the Chief Executive Officer. | |
| Hedging Transactions Prohibited | | | The Company’s insider trading policy prohibits short sales and hedging transactions of shares of the Company’s Common Stock by Directors, officers and employees. | |
| Pledging Prohibited | | | The Company’s insider trading policy was amended in fiscal 2017 to provide that, effective as of June 1, 2017, pledging of shares of the Company’s Common Stock by Directors, officers and employees is prohibited, subject to limited exceptions. | |
| Performance-Based Compensation | | | The Company relies heavily on performance-based compensation for executive officers, including awards of performance-based restricted stock. | |
| Double-Trigger Vesting Provisions | | | The Amended and Restated RPM International Inc. 2014 Omnibus Equity and Incentive Plan (the “2014 Omnibus Plan”) and the proposed RPM International Inc. 2024 Omnibus Equity and Incentive Plan provide double-trigger vesting provisions for long-term equity awards. | |
| Clawback Policies | | | Since 2012, the Company has maintained a clawback policy (the “Clawback Policy”) under which the Board of Directors may require reimbursement of certain bonuses or incentive compensation awarded to an executive officer if, as the result of that executive officer’s misconduct, the Company is required to restate all or a portion of its financial statements. In addition to the Clawback Policy, in October 2023 the Board of Directors adopted the RPM International Inc. Incentive-Based Compensation Clawback Policy (the “NYSE Clawback Policy”) in accordance with newly-adopted NYSE listing standards. The NYSE Clawback Policy provides for the recovery of certain incentive-based compensation in the event of an Accounting Restatement (as defined in the NYSE Clawback Policy). | |
| Chief Executive Officer Succession Planning | | | The Company’s succession plan, which the Board of Directors reviews annually, addresses both an unexpected loss of the Chief Executive Officer as well as longer-term succession. | |
| The Values & Expectations of 168 | | | The Company’s code of business conduct and ethics, entitled “The Values & Expectations of 168,” emphasizes individual responsibility and accountability, encourages reporting and dialogue about business practices, ethics, or integrity concerns, and focuses on the Company’s values of transparency, trust and respect. | |
| Statement of Governance Policy | | | The Board of Directors adopted our Statement of Governance Policy in 2016, which recognizes that conducting our business in conformity with The Values & Expectations of 168 is essential to advancing our fundamental objective of building long-term stockholder value. | |
| | 2024 Proxy Statement | | | 5 |
| RPM INTERNATIONAL INC. STATEMENT OF GOVERNANCE POLICY | |
| RPM International’s fundamental objective is to build long-term stockholder value by profitably growing our businesses and consistently delivering strong financial performance. We think that our ability to generate value for our stockholders is inextricably linked to our ability to provide value to our principal stakeholders, including our customers and associates. • We must continue to earn the ongoing commitment and trust of our stockholders by delivering the solid returns expected by them from an investment in RPM. • We must continue to offer our customers innovative, high-quality products and services at competitive prices. • We must attract and retain high-quality associates at every level of our organization, provide them with the tools they need to do their jobs, and compensate them in such a way as to closely align their interests with our long-term success. • We must conduct our business in conformity with The Values & Expectations of 168, which encompass complying with all legal and ethical standards, and working to be exemplary corporate citizens. We do not focus narrowly on efforts to maximize the short-term price of our stock, and think that such an approach is fundamentally misguided. Instead, we believe that emphasizing consistent value creation in our businesses will maximize the long-term value of our stockholders’ investment. In short, we manage our businesses to create wealth for our stockholders. Creating value for our stakeholders is how we have achieved, and will continue to achieve, that objective. | |
6 | | | 2024 Proxy Statement | | |
| Director Qualifications and Experience | | | Kirkland B. Andrews | | | John M. Ballbach | | | Bruce A. Carbonari | | | Jenniffer D. Deckard | | | Salvatore D. Fazzolari | | | Robert A. Livingston | | | Frederick R. Nance | | | Ellen M. Pawlikowski | | | William B. Summers, Jr. | | | Elizabeth F. Whited | | | Frank C. Sullivan |
| Adherence to The Values & Expectations of 168 Understands and adheres to the code of conduct set forth in The Values & Expectations of 168 | | | • | | | • | | | • | | | • | | | • | | | • | | | • | | | • | | | • | | | • | | | • |
| Leadership and Operating Experience Significant leadership and operating experience | | | • | | | • | | | • | | | • | | | • | | | • | | | • | | | • | | | • | | | • | | | • |
| Independence Satisfies the independence requirements of the NYSE and the SEC | | | • | | | • | | | • | | | • | | | • | | | • | | | • | | | • | | | • | | | • | | | |
| Finance Experience Possesses the background, knowledge, and experience to provide the Company with valuable insight in overseeing the Company’s finances | | | • | | | • | | | • | | | • | | | • | | | • | | | | | • | | | • | | | • | | | • | |
| Public Company Board and Corporate Governance Experience Experience serving on the boards of other publicly traded companies | | | • | | | • | | | • | | | • | | | • | | | • | | | • | | | • | | | • | | | | | • | |
| Environmental, Social and Governance Experience Knowledge of and experience with ESG initiatives | | | • | | | • | | | • | | | • | | | • | | | • | | | • | | | • | | | • | | | • | | | • |
| Knowledge of the Company Experience with the Company for a period in excess of ten years | | | | | | | • | | | | | • | | | | | • | | | | | • | | | | | • | ||||||
| Diversity Contributes to the Board in a way that enhances perspectives through diversity in gender, ethnicity, race and cultural and other backgrounds | | | | | | | | | • | | | | | | | • | | | • | | | | | • | | | |||||||
| Merger and Acquisition Experience Possesses experience or insight related to mergers and acquisitions | | | • | | | • | | | • | | | • | | | • | | | • | | | • | | | • | | | • | | | • | | | • |
| Cybersecurity Experience Knowledge of and experience with cybersecurity matters | | | • | | | • | | | | | | | • | | | | | | | • | | | | | | | • |
| | 2024 Proxy Statement | | | 7 |
* | Upon John M. Ballbach’s retirement at the Annual Meeting, the authorized number of Directors will be fixed at ten. Mr. Ballbach is not included in the statistics shown above. |
8 | | | 2024 Proxy Statement | | |
• | Base salary – $1,065,000, which was a 7% increase over his fiscal 2023 base salary of $995,000; his base salary had been $995,000 for each of fiscal 2023, fiscal 2022, fiscal 2021 and fiscal 2020. |
• | Annual cash incentive compensation – Annual cash incentive compensation of $1,580,000, which was $460,000 more than his fiscal 2023 annual cash incentive compensation. |
• | Equity compensation – Mr. Sullivan received 11,140 Performance Earned Restricted Stock (“PERS”) for fiscal 2024. |
• | Other compensation – Matching contribution of $13,800 under the Company’s 401(k); automobile allowance of $26,089; life insurance premiums of $192,905; matched charitable contributions of $2,000; and financial consulting fees of $15,750. |
| | 2024 Proxy Statement | | | 9 |
| VIRTUAL ANNUAL MEETING INFORMATION | |
| The Company will be hosting a virtual Annual Meeting. Stockholders will be able to participate in the Annual Meeting online, in virtual meeting format, via live webcast. Provided below is the summary of the information that you will need to participate in the Annual Meeting: • Stockholders can participate in the Annual Meeting online, in virtual meeting format, via live webcast over the Internet at www.virtualshareholdermeeting.com/RPM2024. • You will need your unique control number, which is provided on your notice of internet availability or proxy card, to vote and submit questions during the Annual Meeting webcast. • The webcast of the Annual Meeting will begin at 1:30 p.m., Eastern Daylight Time. • Instructions as to how to participate via the Internet, including how to verify stock ownership, are available at www.virtualshareholdermeeting.com/RPM2024. • If you have questions regarding how vote your shares of Common Stock, you may call Innisfree M&A Incorporated, at (877) 800-5195 (Toll Free). • Replay of the Annual Meeting webcast will be available until October 2, 2025. | |
10 | | | 2024 Proxy Statement | | |
| | 2024 Proxy Statement | | | 11 |
• | the classification of the Board of Directors will be phased out over the next three Annual Meetings, such that (i) at the Annual Meeting, each of the Directors in Class II will be elected to hold office for a term of one year, (ii) at the 2025 Annual Meeting of Stockholders, each of the Directors in Class I and Class II will be elected to hold office for a term of one year, and (iii) at the 2026 Annual Meeting of Stockholders, each of the Directors in Class I, Class II and Class III will be elected to hold office for a term of one year, and thereafter the classification of the Board of Directors will terminate in its entirety, and |
• | the term of office of the persons elected as Directors in Class II at this year’s Annual Meeting will expire at the time of the 2025 Annual Meeting of Stockholders. |
| Your Board recommends a vote “FOR” this Amendment. | |
| |
12 | | | 2024 Proxy Statement | | |
• | the classification of the Board of Directors will be phased out over the next three Annual Meetings, such that (i) at the Annual Meeting, each of the Directors in Class II will be elected to hold office for a term of one year, (ii) at the 2025 Annual Meeting of Stockholders, each of the Directors in Class I and Class II will be elected to hold office for a term of one year, and (iii) at the 2026 Annual Meeting of Stockholders, each of the Directors in Class I, Class II and Class III will be elected to hold office for a term of one year, and thereafter the classification of the Board of Directors will terminate in its entirety, and |
• | the term of office of the persons elected as Directors in Class II at this year’s Annual Meeting will expire at the time of the 2025 Annual Meeting of Stockholders. |
• | the term of office of one Class of Directors will expire each year, and at each Annual Meeting of Stockholders the successors to the Directors of the Class whose term is expiring at that time will continue to be elected to hold office for a term of three years, and |
• | the term of office of the persons elected as Directors in Class II at this year’s Annual Meeting will expire at the time of the 2027 Annual Meeting of Stockholders. |
| Your Board recommends a vote “FOR” each director nominee. | |
| Class II Director Nominees • Bruce A. Carbonari • Jenniffer D. Deckard • Salvatore D. Fazzolari | |
| All currently serve as Directors in Class II. | |
| |
| | 2024 Proxy Statement | | | 13 |
Bruce A. Carbonari Director since 2002 Age: 68 Committees: Executive, Governance and Nominating Class: Class II Director Nominee Shares of Common Stock beneficially owned: 42,521 | | | Experience Retired Chair and Chief Executive Officer, Fortune Brands, Inc., a diversified consumer products company. Prior to his retirement, Mr. Carbonari served as the Chair and Chief Executive Officer of Fortune Brands from 2008 to 2011, and as its President and Chief Executive Officer from 2007 to 2008. Previously, he held positions with Fortune Brands business unit, Fortune Brands Home & Hardware LLC, as Chair and Chief Executive Officer from 2005 until 2007 and as President and Chief Executive Officer from 2001 to 2005. Mr. Carbonari was the President and Chief Executive Officer of Fortune Brands Kitchen and Bath Group from 1998 to 2001 and was previously the President and Chief Executive Officer of Moen, Inc. from 1990 to 1998. Prior to joining Moen in 1990, Mr. Carbonari was Executive Vice President and Chief Financial Officer of Stanadyne, Inc., Moen’s parent company at that time. He began his career at PricewaterhouseCoopers prior to joining Stanadyne in 1981. | ||||||
| Reasons for Nomination The Board of Directors has determined that Mr. Carbonari should serve as a Director because of his extensive executive management experience, including his service as Chair and Chief Executive Officer of Fortune Brands, Inc. In that position, Mr. Carbonari dealt with many of the major issues, such as financial, strategic, technology, compensation, management development, acquisitions, capital allocation, government and stockholder relations, that the Company deals with today. | | | Key Skills • Financial • Strategic • Technology • Compensation • Management Development | | | • Acquisitions • Capital Allocation • Government and Stockholder Relations | ||
|
14 | | | 2024 Proxy Statement | | |
Jenniffer D. Deckard Director since 2015 Age: 58 Committee: Audit Class: Class II Director Nominee Shares of Common Stock beneficially owned: 14,845 | | | Experience Chief Finance and Administrative Officer of The Sisters of Notre Dame of the United States (“SND”). The SND is a community of religious women whose ministries include, but are not limited to, the founding and serving of dozens of faith-based educational institutions from pre-schools to a college, multiple faith-based retirement communities and a hospital. Ms. Deckard is the first lay person to manage finances, administration and operations for the SND. Former President and Chief Executive Officer of Covia Holdings Corporation, a leading provider of minerals and materials solutions for the industrial and energy markets (formerly, NYSE: CVIA). Ms. Deckard also served as a director on Covia’s board of directors from 2018 until May 2019. Covia filed a voluntary petition for relief under Chapter 11 of the U.S. Bankruptcy Code in June 2020. Ms. Deckard previously served as President, Chief Executive Officer and director of Fairmount Santrol Holdings Inc. from 2013 until 2018, when Fairmount Santrol and Unimin Corporation merged to form Covia. Previously, Ms. Deckard served as Fairmount Santrol’s President from 2011 until 2013, Vice President of Finance and Chief Financial Officer from 1999 until 2011, Corporate Controller from 1996 to 1999 and Accounting Manager from 1994 until 1996. Ms. Deckard also serves on the board of the Great Lakes Construction Company, an Ohio-based heavy civil engineering and construction company, where Ms. Deckard serves on the board’s investment, audit and ESOP advisory committees. Ms. Deckard also serves on the non-profit boards of the University Hospitals and the Edwins Foundation, serving on the finance committee for University Hospitals. Ms. Deckard received a bachelor of science from the University of Tulsa and a M.B.A. degree from Case Western Reserve University. | ||||||
| Reasons for Nomination The Board of Directors has determined that Ms. Deckard should serve as a Director because of her extensive executive management experience and financial expertise, including her service as President and Chief Executive Officer of Covia. In that position, Ms. Deckard dealt with many of the major issues, such as financial, strategic, technology, compensation, management development, acquisitions, capital allocation, government and stockholder relations, that the Company deals with today. She was integral in the creation of Fairmount Santrol’s (and later Covia’s) industry-leading sustainable development program and has significant experience in ESG-related matters. With her extensive financial background, Ms. Deckard is a financial expert for the Company’s Audit Committee. Ms. Deckard also provides the Board of Directors a valuable perspective as a member of the boards of several prominent local non-profit organizations. | | | Key Skills • Financial • Strategic • Technology • Compensation • Management Development | | | • Acquisitions • Capital Allocation • Government and Stockholder Relations | ||
|
| | 2024 Proxy Statement | | | 15 |
Salvatore D. Fazzolari Director since 2013 Age: 72 Committees: Audit, Executive Class: Class II Director Nominee Shares of Common Stock beneficially owned: 19,549 | | | Experience Former Chair, President and Chief Executive Officer of Harsco Corporation (now known as Enviri Corp.), a global environmental solutions company. Mr. Fazzolari served as Chair and Chief Executive Officer of Harsco Corporation from 2008 until 2012, in addition to serving as its President from 2010 until 2012. During the course of his over 30 years of service to Harsco Corporation, Mr. Fazzolari held various other positions, including President (2006 – 2007), Chief Financial Officer (1998 – 2007) and Treasurer and Corporate Controller. Mr. Fazzolari is a certified public accountant (inactive) and a certified information systems auditor (inactive). He serves on the board of directors of Bollman Hat Company and RDG Companies (a developer, investor and general partner in real estate transactions). He previously served on the board of directors of Gannett Fleming, Inc. until December 2022. He earned his bachelor of business administration degree in accounting from Pennsylvania State University. | ||||||
| Reasons for Nomination The Board of Directors has determined that Mr. Fazzolari should serve as a Director because of his extensive executive management experience, including his service as Chair, President and Chief Executive Officer of Harsco Corporation. In that position, Mr. Fazzolari dealt with many of the major issues, such as financial, strategic, technology, compensation, management development, acquisitions, capital allocation, government, environmental solutions and stockholder relations, that the Company deals with today. Mr. Fazzolari has almost four decades of extensive experience in the metals and minerals markets in developing innovative solutions that significantly improve the environment. His past board service includes chairing an audit committee where he was responsible for overseeing cybersecurity matters. Also, Mr. Fazzolari has extensive global experience, and because of his considerable financial background, he is a financial expert for the Company’s Audit Committee and serves as its chair. | | | Key Skills • Financial • Strategic • Technology • Compensation • Management Development | | | • Acquisitions • Capital Allocation • Government and Stockholder Relations • Environmental Solutions | ||
|
16 | | | 2024 Proxy Statement | | |
Kirkland B. Andrews Director since 2018 Age: 56 Committee: Audit Class: Director in Class I (term expiring in 2025) Shares of Common Stock beneficially owned: 11,628 | | | Experience Senior Vice President and Chief Financial Officer of Consolidated Edison, Inc. (NYSE: ED), one of the nation’s largest investor-owned energy-delivery companies (“Con Edison”), and Consolidated Edison Company of New York, Inc., since July 2024. Previously, Mr. Andrews served as Executive Vice President and Chief Financial Officer of Evergy, Inc. (NYSE: EVRG), a regulated utility holding company serving 1.6 million customers in Kansas and Missouri, from February 2021 until July 2024. From March 2020 until February 2021, Mr. Andrews had been a director of Evergy, where he was a member of the audit committee, the power delivery and safety committee, and the strategic review and operations committee. Prior to that, Mr. Andrews was Executive Vice President and Chief Financial Officer of NRG Energy, Inc. (NYSE: NRG) from 2011 until February 2021. Mr. Andrews was a director of NRG Yield, Inc. from 2012 until 2018 (when NRG Yield, Inc. became Clearway Energy, Inc.), and also served as Executive Vice President, Chief Financial Officer of NRG Yield, Inc. from 2012 to 2016. Mr. Andrews also previously served as Chief Financial Officer of GenOn Energy, Inc., a wholly-owned subsidiary of NRG, which filed a voluntary petition for relief under Chapter 11 of the U.S. Bankruptcy Code in 2017. Prior to joining NRG, he served as Managing Director and Co-Head Investment Banking, Power and Utilities – Americas at Deutsche Bank Securities from 2009 to 2011. Prior to that, he served in several capacities at Citigroup Global Markets Inc., including Managing Director, Group Head, North American Power from 2007 to 2009, and Head of Power M&A, Mergers and Acquisitions from 2005 to 2007. In his banking career, Mr. Andrews led multiple large and innovative strategic, debt, equity and commodities transactions. | ||||||
| Reasons for Nomination Mr. Andrews was initially appointed as a Director pursuant to the Cooperation Agreement, dated June 27, 2018, among the Company and Elliott Associates, L.P., Elliott International, L.P. and Elliott International Capital Advisors Inc. related to, among other things, appointment of additional Directors to the Board of Directors. The Board of Directors has determined that Mr. Andrews should serve as a Director because of his extensive executive management experience and his considerable financial background as Con Edison’s Senior Vice President and Chief Financial Officer. At Con Edison, Mr. Andrews deals with many of the major issues, such as financial, strategic, technology, management development, acquisitions and capital allocation, that the Company deals with today. Also, with his extensive financial background, Mr. Andrews is a financial expert for the Company’s Audit Committee. As previously disclosed in the Company’s Current Report on Form 8-K dated July 25, 2024, Mr. Andrews has informed the Board of Directors that he intends to step down as a Director before his term expires at the Annual Meeting of Stockholders in October 2025. The Board of Directors currently anticipates that the effective date of Mr. Andrews’ resignation will be at the conclusion of the Board of Directors’ regularly scheduled meeting on January 15, 2025. Mr. Andrews also will step down as a member of the Audit Committee at such time. | | | Key Skills • Financial • Strategic • Technology | | | • Management Development • Acquisitions • Capital Allocation | ||
|
| | 2024 Proxy Statement | | | 17 |
General Ellen M. Pawlikowski (Retired) Director since 2022 Age: 67 Committee: Governance and Nominating Class: Director in Class I (term expiring in 2025) Shares of Common Stock beneficially owned: 3,700 | | | Experience Gen. Pawlikowski is a retired four-star general of the U.S. Air Force and was the third woman to achieve this rank. In her last assignment, she served as Commander, Air Force Materiel Command, Wright-Patterson Air Force Base, Ohio, from 2015 until 2018. Gen. Pawlikowski entered active duty with the Air Force in 1982, and her distinguished 36-year career spanned a wide variety of technical management, leadership, and staff positions of increasing responsibility. She commanded five times as a general officer, commanding the MILSATCOM Systems Wing, the Air Force element of the National Reconnaissance Office, the Air Force Research Laboratory, the Space and Missile Systems Center, and Air Force Materiel Command. Nationally recognized for her leadership and technical management acumen, Gen. Pawlikowski has received the Women in Aerospace Life-Time Achievement Award, the National Defense Industrial Association’s Peter B. Teets Award, and the Air Force Association Executive Management Award. She is an Honorary Fellow of the American Institute of Aeronautics and Astronautics and a member of the National Academy of Engineers. She has served as a director of RTX Corporation (formerly Raytheon Technologies Corporation) (NYSE: RTX) since 2020. She was previously a director of Raytheon Company from 2018 until 2020, Intelsat S.A. from 2019 until February 2022, and Velo3D, Inc. (NYSE: VLD) from 2022 until June 2023. | ||||||
| Reasons for Nomination The Board of Directors has determined that Gen. Pawlikowski should serve as a Director because of the extensive senior leadership and management experience she gained during her distinguished military career in which she ultimately became a four-star general in the U.S. Air Force. As Commander, Air Force Materiel Command, Gen. Pawlikowski commanded 80,000 personnel and managed a budget of $60 billion on an annual basis. Her responsibilities included addressing environmental, energy efficiency and conservation matters concerning U.S. Air Force operations, and Gen. Pawlikowski helped develop the U.S. Air Force’s cybersecurity plan. Her experience enables her to assist the Company with leadership development and provides a unique strategic perspective to the Company. | | | Key Skills • Finance • Strategic • Technology • Cybersecurity • ESG | | | • ESG • Management Development • Acquisitions • Capital Allocation | ||
|
18 | | | 2024 Proxy Statement | | |
Frank C. Sullivan Director since 1995 Age: 63 Committee: Executive Class: Director in Class I (term expiring in 2025) Shares of Common Stock beneficially owned: 1,361,998 | | | Experience Chair, President and Chief Executive Officer, RPM International Inc. Mr. Sullivan entered the University of North Carolina as a Morehead Scholar and received his B.A. degree in 1983. From 1983 to 1987, Mr. Sullivan held various commercial lending and corporate finance positions at Harris Bank and First Union National Bank prior to joining RPM as Regional Sales Manager from 1987 to 1989 at RPM’s AGR Company joint venture. In 1989, he became RPM’s Director of Corporate Development. He became a Vice President in 1991, Chief Financial Officer in 1993, Executive Vice President in 1995, President in 1999, Chief Operating Officer in 2001, Chief Executive Officer in 2002, and was elected Chair of the Board in 2008 and President in 2018. Since 2003, Mr. Sullivan has been a director of The Timken Company, a global manufacturer of engineered bearings and power transmission products (NYSE: TKR), where he serves on both Timken’s compensation committee and its nominating and corporate governance committee. He also serves on the boards of the American Coatings Association, the Cleveland Clinic, the Cleveland Rock and Roll Hall of Fame and Museum, Greater Cleveland Partnership and the Ohio Business Roundtable. | ||||||
| Reasons for Nomination The Board of Directors has determined that Mr. Sullivan should serve as a Director because of his role as the Company’s Chief Executive Officer, his intimate knowledge of the Company, and his experience serving as a director of another public company and non-profit organizations. The Board of Directors believes that Mr. Sullivan’s extensive experience in and knowledge of the Company’s business gained as a result of his long-time service as a member of management is essential to the Board of Directors’ oversight of the Company and its business operations. The Board of Directors also believes that continuing participation by qualified members of the Sullivan family on the Board of Directors is an important part of the Company’s corporate culture that has contributed significantly to its long-term success. | | | Key Skills • Finance • Strategic • Leadership and Operating Experience • Acquisitions | | | • Capital Allocation • Vast Knowledge of the Company • Important Part of the Company’s Corporate Culture | ||
|
| | 2024 Proxy Statement | | | 19 |
Elizabeth F. Whited Director since 2021 Age: 59 Committee: Compensation Class: Director in Class I (term expiring in 2025) Shares of Common Stock beneficially owned: 4,300 | | | Experience Elizabeth F. Whited is president of Union Pacific Corporation, one of America’s leading transportation companies (NYSE: UNP), where her responsibilities include the strategy, workforce resources, sustainability, law, corporate relations and government affairs functions. From February 2022 until July 2023, Ms. Whited served as Union Pacific’s executive vice president – sustainability and strategy, where she helped develop and implement Union Pacific’s strategic vision and led Union Pacific’s human resources organization, pioneering efforts to provide a world-class employee experience. Ms. Whited continues to lead environmental, social and governance (“ESG”) efforts at Union Pacific and was named to Constellation Research’s “ESG 50” in 2023 in recognition of Union Pacific’s strides in sustainability. After joining Union Pacific in 1987, Ms. Whited held a variety of executive roles in strategic planning, investor relations, ESG, finance, and marketing and sales, including president of subsidiary Union Pacific Distributions Services. In 2016, she was named executive vice president and chief marketing officer, and in 2018, she was named executive vice president and human resource officer. Ms. Whited served as executive vice president – sustainability and strategy from February 2022 until she was appointed to her current role as president in July 2023. Ms. Whited holds a bachelor’s degree in business administration from the University of Iowa. | ||||||
| Reasons for Nomination The Board of Directors has determined that Ms. Whited should serve as a Director because of her extensive management experience, including her service as president at Union Pacific as well as her prior executive roles. In those positions, Ms. Whited has dealt with many of the major issues, such as sustainability, strategic planning, human resources, investor relations, ESG, finance, and marketing and sales, that the Company deals with today. | | | Key Skills • Sustainability • Strategic Planning • Human Resources • Stockholder Relations | | | • ESG • Finance • Acquisitions • Capital Allocation • Marketing and Sales | ||
|
20 | | | 2024 Proxy Statement | | |
Robert A. Livingston Director since 2017 Age: 70 Committees: Compensation, Executive Class: Director in Class III (term expiring in 2026) Shares of Common Stock beneficially owned: 16,159 | | | Experience Retired President and Chief Executive Officer, Dover Corporation, a $8.5 billion diversified manufacturer (NYSE: DOV). Mr. Livingston served as Dover’s President and Chief Executive Officer from 2008 until his retirement in 2018. Previously, he held positions with Dover business units Dover Engineered Systems, Inc. (as President and Chief Executive Officer) from 2007 until 2008, and Dover Electronics, Inc. (as President and Chief Executive Officer) from 2004 until 2007. Mr. Livingston was previously the President of Vectron International, Inc., a Dover business unit, from 2001 until 2004, and the Executive Vice President (from 1998 until 2001) and Vice President, Finance and Chief Financial Officer (from 1987 until 1998) of Dover Technologies, Inc. Prior to its acquisition by Dover in 1983, Mr. Livingston was Vice President, Finance of K&L Microwave, and continued to serve in that capacity until 1984, when he became Vice President and General Manager of K&L Microwave until 1987. Mr. Livingston was a director of Dover Corporation from 2008 until his retirement in 2018. Since December 2018, Mr. Livingston has been a director of Amphenol Corporation, a manufacturer of electrical and fiber optic connectors and interconnect systems (NYSE: APH), where he serves on Amphenol’s audit, compensation (which he chairs) and executive committees. Mr. Livingston received his B.S. degree in business administration from Salisbury University. | ||||||
| Reasons for Nomination The Board of Directors has determined that Mr. Livingston should serve as a Director because of his extensive executive management experience, including his service as President and Chief Executive Officer of Dover. In that position, Mr. Livingston dealt with many of the major issues, such as financial, strategic, technology, compensation, management development, acquisitions, capital allocation, government and investor relations, that the Company deals with today. | | | Key Skills • Financial • Strategic • Technology • Compensation • Management Development | | | • Acquisitions • Capital Allocation • Government and Stockholder Relations | ||
|
| | 2024 Proxy Statement | | | 21 |
Frederick R. Nance Director since 2007 Age: 70 Committees: Executive, Governance and Nominating Class: Director in Class III (term expiring in 2026) Shares of Common Stock beneficially owned: 8,180 | | | Experience Executive Group Member and Global DEI Counsel of Squire Patton Boggs (US) LLP, Attorneys-at-law, which serves clients from 40 offices across four continents. He received his B.A. degree from Harvard University and his J.D. degree from the University of Michigan. Mr. Nance joined Squire Patton Boggs directly from law school, became partner in 1987, served as the Managing Partner of the firm’s Cleveland office from 2002 until 2007, and served as the firm’s Regional Managing Partner from 2007 until 2017. From 2017 until the end of 2022, Mr. Nance served as the firm’s Global Managing Partner. Mr. Nance also served two four-year terms on the firm’s worldwide, seven-person Management Committee. In addition to his duties at Squire Patton Boggs, where he heads the firm’s U.S. Sports and Entertainment practice representing clients including LeBron James, Mr. Nance serves on the board of the Cleveland Clinic, where he chairs the governance committee. Mr. Nance previously served on the board of the Greater Cleveland Partnership, which he chaired, and the board of McDonald & Company Investments, Inc. In 2015, Mr. Nance was inducted into the Northeast Ohio Business Hall of Fame. | ||||||
| Reasons for Nomination The Board of Directors has determined that Mr. Nance should serve as a Director primarily due to his significant legal background and global management experience. As Global DEI Counsel of Squire Patton Boggs (US) LLP, Mr. Nance oversees a multinational staff pursuing diversity and inclusion efforts for thousands of partners and employees across the globe. Mr. Nance’s background allows him to provide valuable insights to the Board of Directors, particularly in regard to corporate governance and risk issues that confront the Company. Mr. Nance also provides the Board of Directors a valuable perspective as a current or past member of the boards of several prominent local non-profit organizations. | | | Key Skills • Management Development • Acquisitions • Capital Allocation | | | • Corporate Governance • Risk Management • Non-profit Organizations | ||
|
22 | | | 2024 Proxy Statement | | |
William B. Summers, Jr., Director since 2004 Age: 74 Committee: Compensation Class: Director in Class III (term expiring in 2026) Shares of Common Stock beneficially owned: 46,188 | | | Experience Retired Chair and Chief Executive Officer of McDonald Investments Inc., an investment banking and securities firm and a part of KeyBanc Capital Markets. Prior to his retirement, Mr. Summers served as Chair of McDonald Investments Inc. from 2000 to 2006, and as its Chief Executive Officer from 1994 to 2000. From 1998 until 2000, Mr. Summers served as the Chair of Key Capital Partners and an Executive Vice President of KeyCorp. Mr. Summers is a director of Integer Holdings Corporation, a medical device outsource manufacturer (NYSE: ITGR), and a member of the advisory board of Citymark Capital. From 2004 until 2011, Mr. Summers was a director of Developers Diversified Realty Corporation. Mr. Summers was previously a member of the New York Stock Exchange board of directors and a member of the Nasdaq Stock Market board of directors, and served as the chair of the Nasdaq Stock Market board of directors for two years. Mr. Summers is a trustee of Baldwin Wallace University and a Life Trustee of the Rock & Roll Hall of Fame and Museum. | ||||||
| Reasons for Nomination The Board of Directors has determined that Mr. Summers should serve as a Director because of his extensive executive management experience, including over 15 years of experience as Chair and Chief Executive Officer of McDonald Investments Inc., service on the boards of both the New York Stock Exchange and the Nasdaq Stock Market, and his experience serving as a director of other private and public companies. His experience enables Mr. Summers to provide keen insight and diverse perspectives on several critical areas impacting the Company, including capital markets, financial and external reporting, long-term strategic planning and business modeling. Mr. Summers also provides the Board of Directors a valuable perspective as a member of the boards of several prominent local non-profit organizations. | | | Key Skills • Finance • Strategic • Management Development • Acquisitions | | | • Capital Allocation • Non-profit Organizations | ||
|
| | 2024 Proxy Statement | | | 23 |
24 | | | 2024 Proxy Statement | | |
| Name | | | Audit Committee | | | Compensation Committee | | | Executive Committee | | | Governance and Nominating Committee | |
| Kirkland B. Andrews | | | • | | | | | | | | |||
| John M. Ballbach | | | | | | | | | • | | |||
| Bruce A. Carbonari* | | | | | | | • | | | • | | ||
| Jenniffer D. Deckard | | | • | | | | | | | | |||
| Salvatore D. Fazzolari | | | | | | | • | | | | |||
| Robert A. Livingston | | | | | | | • | | | | |||
| Frederick R. Nance | | | | | | | • | | | | |||
| Ellen M. Pawlikowski | | | | | | | | | • | | |||
| William B. Summers, Jr. | | | | | • | | | | | | |||
| Elizabeth F. Whited | | | | | • | | | | | | |||
| Frank C. Sullivan | | | | | | | | | | ||||
| Number of Meetings | | | 5 | | | 4 | | | 0 | | | 3 | |
Audit Committee Chair Salvatore D. Fazzolari Members Kirkland B. Andrews Jenniffer D. Deckard | | | Key Responsibilities • The Audit Committee assists the Board of Directors in fulfilling its oversight of the integrity of the Company’s financial statements, the Company’s compliance with legal and regulatory requirements, the independent auditor’s qualifications and independence, the performance of the Company’s internal audit function and independent auditor and prepares the report of the Audit Committee. • The Audit Committee also oversees the Company’s cybersecurity and data privacy risk management programs, establishes procedures for the receipt of reports on cybersecurity, data privacy and other risks relevant to the Company’s information system controls and security, and establishes procedures for the receipt and review of reports of cybersecurity and data privacy incidents in accordance with the Company’s cybersecurity and data privacy escalation procedures. • The specific functions and responsibilities of the Audit Committee are set forth in the Audit Committee Charter which is available on the Company’s website. | |
| | The Board of Directors has determined that each member of the Audit Committee is financially literate and satisfies the current independence standards of the NYSE listing standards and Section 10A(m)(3) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Board of Directors has also determined that each member of the Audit Committee qualifies as an “audit committee financial expert” as that term is defined in Item 407(d) of Regulation S-K. Each of Ms. Deckard and Messrs. Andrews and Fazzolari also satisfies the NYSE accounting and financial management expertise requirements. |
| | 2024 Proxy Statement | | | 25 |
Compensation Committee Chair Robert A. Livingston Members William B. Summers, Jr. Elizabeth F. Whited | | | Key Responsibilities • The Compensation Committee assists the Board of Directors in discharging its oversight responsibilities relating to, among other things, executive compensation, equity and incentive compensation plans, management succession planning and producing the Compensation Committee Report. • The Compensation Committee administers the Company’s Incentive Compensation Plan and 2014 Omnibus Plan. • The Compensation Committee reviews and determines the salary and incentive compensation of the Chief Executive Officer, as well as reviews and recommends to the Board of Directors for its approval the compensation of the other executive officers of the Company. • The Compensation Committee may delegate its authority to a subcommittee or subcommittees. | |
| | Each member of the Compensation Committee is independent within the meaning of the NYSE listing standards and the Company’s Corporate Governance Guidelines. | ||
| | Our Chief Executive Officer, together with the Compensation Committee, reviews assessments of executive compensation practices at least annually against our defined Comparative Framework. Our Chief Executive Officer makes recommendations to the Compensation Committee with the intent of keeping our executive officer pay practices aligned with our intended pay philosophy. The Compensation Committee must approve any recommended changes before they can be made. The Compensation Committee has the sole authority to retain and terminate any compensation and benefits consultant, independent legal counsel or other adviser, to assess the independence of such advisers and any potential conflicts of interest prior to engagement, and to approve the related fees and other retention terms of such advisers. | ||
| | Before selecting any compensation and benefits consultant, independent legal counsel or other adviser, the Compensation Committee takes into account all factors relevant to that adviser’s independence from management, including the following six factors: • the provision of other services to the Company by the adviser’s employer; • the amount of fees received from the Company by the adviser’s employer, as a percentage of total revenues of the employer; • the policies and procedures of the adviser’s employer that are designed to prevent conflicts of interest; • any business or personal relationship of the adviser with a member of the Compensation Committee; • any Common Stock of the Company owned by the adviser; and • any business or personal relationship of the adviser or the adviser’s employer with an executive officer of the Company. |
26 | | | 2024 Proxy Statement | | |
Governance and Nominating Committee Chair Frederick R. Nance Members John M. Ballbach Bruce A. Carbonari Ellen M. Pawlikowski | | | Key Responsibilities The Governance and Nominating Committee reports to the Board of Directors on all matters relating to corporate governance of the Company, including: • the development and recommendation to the Board of Directors of a set of corporate governance principles applicable to the Company; • selection, qualification and nomination of the members of the Board of Directors and nominees to the Board of Directors; • administration of the Board’s evaluation process; and • oversight of the Company’s efforts to identify and manage sustainability risks and opportunities, and the development and implementation of goals the Company may establish from time to time relating to same. | |
| | Each of the members of the Governance and Nominating Committee is independent within the meaning of the NYSE listing standards and the Company’s Corporate Governance Guidelines. | ||
| | In identifying and considering possible candidates for election as a Director, the Governance and Nominating Committee, after consultation with the Board and the Chief Executive Officer, will consider all relevant factors and will be guided by the following principles: (1) each Director should be an individual of the highest character and integrity; (2) each Director shall have demonstrated exceptional ability and judgment and should have substantial experience which is of particular relevance to the Company; (3) each Director should have sufficient time available to devote to the affairs of the Company; and (4) each Director should represent the best interests of the stockholders as a whole rather than special interest groups. This evaluation is performed in light of the Governance and Nominating Committee’s views as to the needs of the Board of Directors and the Company as well as what skill set and other characteristics would most complement those of the current Directors. | ||
| | The Governance and Nominating Committee and the Board of Directors consider a diverse group of experiences, characteristics, attributes and skills, including diversity in gender, ethnicity, race, cultural background and age, in determining whether an individual is qualified to serve as a Director of the Company. | ||
| | Furthermore, in fiscal 2020, the Governance and Nominating Committee adopted the “Rooney Rule” under which the Governance and Nominating Committee set forth in its Charter its commitment to include, for the purposes of filling any vacancies on the Board of Directors, qualified candidates who reflect diverse backgrounds, including diversity of gender and ethnicity, in each search for new Directors. | ||
| | The Governance and Nominating Committee and the Board of Directors also consider the composition of the Board of Directors as a whole in evaluating whether a particular individual should serve on the Board of Directors, as the Board of Directors seeks to comprise itself of members which, collectively, possess a range of relevant skills, experience and expertise. | ||
| | The Governance and Nominating Committee will consider potential candidates recommended by stockholders, current Directors, Company officers, employees and others. The Governance and Nominating Committee will use the above enumerated factors to consider potential candidates regardless of the source of the recommendation. Stockholder recommendations for director nominations may be submitted to the Secretary of the Company at 2628 Pearl Road, Medina, Ohio 44256, and they will be forwarded to the Governance and Nominating Committee for consideration, provided such recommendations are accompanied by sufficient information to permit the Governance and Nominating Committee to evaluate the qualifications and experience of the potential candidates. Recommendations should include, at a minimum, the following: • the name, age, business address and residence address of the proposed nominee; • the principal occupation or employment of the proposed nominee; • the number of shares of Common Stock which are beneficially owned by such candidate; |
| | 2024 Proxy Statement | | | 27 |
| | • a description of all arrangements or understandings between the stockholder(s) making such nomination and each candidate and any other person or persons (naming such person or persons) pursuant to which nominations are to be made by the stockholder; • detailed biographical data, qualifications and information regarding any relationships between the candidate and the Company within the past three years; • any other information relating to the proposed nominee that would be required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for election of directors pursuant to Section 14 of the Exchange Act and the rules and regulations promulgated thereunder; • any other information the stockholder believes is relevant concerning the proposed nominee; • a written consent of the proposed nominee(s) to being named as a nominee and to serve as a director if elected; • a written agreement of the proposed nominee(s) to comply with the provisions of the Company’s majority voting policy; • the name and record address of the stockholder who is submitting the notice; and • the number of shares of Common Stock which are owned of record or beneficially by the stockholder who is submitting the notice and the date such shares were acquired by the stockholder and if such person is not a stockholder of record or if such shares are owned by an entity, reasonable evidence of such person’s ownership of such shares or such person’s authority to act on behalf of such entity. | ||
| | Stockholders who desire to nominate a proposed nominee for Director at an Annual Meeting must also comply with the requirements set forth in the By-Laws concerning such nominations. | ||
| | Furthermore, in fiscal 2024, the Board of Directors approved and adopted an amendment to the By-Laws to add a proxy access by-law. The proxy access by-law permits a stockholder or a group of up to 20 stockholders that has owned three percent or more of the Company’s outstanding Common Stock continuously for at least three years to nominate, and include in the Company’s proxy materials for its Annual Meeting, candidates for Director constituting up to the greater of (i) two Directors or (ii) 20% of the number of the Company’s Directors then-serving on the Board of Directors, provided that the stockholder(s) and the nominee(s) satisfy the requirements specified in the proxy access by-law. |
28 | | | 2024 Proxy Statement | | |
• | presides at all executive sessions of the independent Directors or other meetings at which the Chair of the Board is not present; |
• | is authorized to call meetings of the independent Directors; |
• | works with the Chair of the Board to call Board meetings; |
• | serves as a liaison between the Chair of the Board and the independent Directors as required (each Director is free, however, to communicate directly with the Chair of the Board); |
• | works with the Chair of the Board to set and approve the Board schedule and agenda to ensure sufficient time for discussion of all agenda items; |
• | approves the materials to be provided to the Board; |
• | consults with other Directors and facilitates communication between the Board and the Chief Executive Officer; |
• | serves as focal point for stockholder communications and requests for consultation addressed to the independent Directors; |
• | has the ability to retain outside professionals on behalf of the Board as the Board may determine is necessary or appropriate; and |
• | performs such other functions either specified in the Corporate Governance Guidelines or assigned from time to time by the Board. |
| | 2024 Proxy Statement | | | 29 |
• | overseeing the Company’s cybersecurity and data privacy risk management programs; |
• | establishing procedures for the receipt of reports on cybersecurity, data privacy and other risks relevant to the Company’s information system controls and security, which reports shall include a review of the cybersecurity risks facing the Company, the Company’s strategies to mitigate these risks and the Company’s cybersecurity crisis preparedness; and |
• | establishing procedures for the receipt and review of reports of cybersecurity and data privacy incidents in accordance with the Company’s cybersecurity and data privacy escalation procedures. |
• | overseeing the Company’s efforts to identify sustainability risks and opportunities; and |
• | developing and implementing goals the Company may establish from time to time relating to same. |
30 | | | 2024 Proxy Statement | | |
• | does not relate to the business or affairs of the Company or the functioning or constitution of the Board of Directors or any of its Committees; or |
• | relates to routine or insignificant matters that do not warrant the attention of the Board of Directors. |
| | 2024 Proxy Statement | | | 31 |
| Your Board recommends a vote “FOR” this resolution. | |
| |
32 | | | 2024 Proxy Statement | | |
* | $100 invested on May 31, 2019 in stock or index, including reinvestment of dividends. Fiscal year ending May 31. |
** | Fiscal 2024 peer group of eight companies includes Akzo Nobel N.V., Axalta Coating Systems Ltd., Carlisle Companies Inc., H.B. Fuller Company, Masco Corporation, PPG Industries, Inc., The Sherwin-Williams Company and Sika AG. |
* | $100 invested on May 31, 2014 in stock or index, including reinvestment of dividends. Fiscal year ending May 31. |
** | Fiscal 2024 peer group of eight companies includes Akzo Nobel N.V., Axalta Coating Systems Ltd., Carlisle Companies Inc., H.B. Fuller Company, Masco Corporation, PPG Industries, Inc., The Sherwin-Williams Company and Sika AG. |
| | 2024 Proxy Statement | | | 33 |
• | Frank C. Sullivan, our Chair, President and Chief Executive Officer; |
• | Russell L. Gordon, our Vice President and Chief Financial Officer; |
• | Edward W. Moore, our Senior Vice President, General Counsel and Chief Compliance Officer; |
• | Janeen B. Kastner, our Vice President – Corporate Benefits and Risk Management; and |
• | Timothy R. Kinser, our Vice President – Operations. |
• | Consolidated net sales increased 1.1% to $7.34 billion in fiscal 2024 from $7.26 billion in fiscal 2023; |
• | Net income attributable to RPM International Inc. stockholders increased 22.9% to $588.4 million in fiscal 2024 from $478.7 million in fiscal 2023; and |
• | Diluted earnings per share increased 22.6% to $4.56 in fiscal 2024 from $3.72 in fiscal 2023; and |
• | Cash provided by operating activities increased to $1.12 billion in fiscal 2024 from $577.1 million in fiscal 2023, with the increase driven by improved profitability and working capital efficiency, both of which were enabled by MAP 2025 initiatives. |
34 | | | 2024 Proxy Statement | | |
• | Increased base salaries from fiscal 2023 levels for all named executive officers; |
• | Awarded Performance Earned Restricted Stock (“PERS”) grants at 85% of target amounts for fiscal year 2024; and |
• | Under the Incentive Plan for fiscal 2024, increased cash awards by $460,000 for Mr. Sullivan, $203,000 for Mr. Gordon, $157,000 for Mr. Moore, $156,000 for Ms. Kastner and $165,000 for Mr. Kinser. |
• | The leadership structure of our Board consists of a Chair (who is also our Chief Executive Officer), a Lead Director (who leads the meetings of our independent Directors held in January, April and July of each year), and strong Board Committee chairs. |
• | We maintain a majority voting policy for the election of Directors in uncontested elections, and require an offer to resign by any incumbent Director who does not receive more votes “for” election than “withheld.” |
• | The Compensation Committee is composed solely of independent Directors who have established methods to communicate with stockholders regarding their executive compensation ideas and concerns. |
• | The Compensation Committee conducts an annual review and approval of our compensation strategy, including a review of our compensation-related risk profile, to ensure that our compensation-related risks are not reasonably likely to have a material adverse effect on the Company. |
• | We maintain stock ownership guidelines for our executive officers and Directors, each of whom either satisfied the applicable ownership guidelines as of May 31, 2024 or is within the grace period for achieving such ownership thresholds. |
• | Our insider trading policy prohibits short sales, pledging and hedging transactions of shares of our Common Stock by Directors, officers and employees. |
• | Use of performance-based compensation arrangements that use a variety of performance measures, including performance-based equity awards. |
• | We maintain incentive-based compensation clawback policies, which apply to the Company’s executive officers. |
• | Our 2014 Omnibus Plan and our proposed RPM International Inc. 2024 Omnibus Equity and Incentive Plan (the “2024 Omnibus Plan”) prohibit the repricing of stock options or stock appreciation rights without stockholder approval. |
• | Our 2014 Omnibus Plan and our proposed 2024 Omnibus Plan provide double-trigger vesting provisions for long-term equity awards in the event of a change in control of the Company. |
| | 2024 Proxy Statement | | | 35 |
36 | | | 2024 Proxy Statement | | |
• | Hire the best people you can find. |
• | Create an atmosphere that will keep them. |
• | Then let them do their jobs. |
| | 2024 Proxy Statement | | | 37 |
| Albemarle Corporation | | | Avient Corporation | | | Axalta Coating Systems Ltd. | | | Cabot Corporation | |
| Carlisle Companies Incorporated | | | Celanese Corporation | | | Eastman Chemical Company | | | H.B. Fuller Company | |
| Huntsman Corporation | | | Masco Corporation | | | Olin Corporation | | | PPG Industries Inc. | |
| The Chemours Company | | | The Scotts Miracle-Gro Company | | | The Sherwin-Williams Company | | | Westlake Chemical Corporation | |
38 | | | 2024 Proxy Statement | | |
• | Base salary; |
• | Annual cash incentive compensation; and |
• | Performance-based equity incentives, including restricted stock. |
| | 2024 Proxy Statement | | | 39 |
| Type of Pay | | | Compensation Component | | | Key Characteristics | | | Purpose | |
| Fixed | | | Base Salary | | | Fixed compensation, reviewed and adjusted annually if and when appropriate | | | Compensate named executive officers fairly for the responsibility level of the position held | |
| Health and Retirement Plans | | | Fixed compensation | | | Intended to provide benefits that promote employee health and support employees in attaining financial security | | |||
| Perks and Other Personal Benefits | | | Fixed compensation | | | Intended to provide a business-related benefit to the Company, and to assist in attracting and retaining executive officers | | |||
| Post-Employment Compensation and Change in Control | | | Fixed compensation | | | Intended to provide temporary income following a named executive officer’s involuntary termination of employment and, in the case of a change of control, to also provide continuity of management | | |||
| Equity Compensation — Supplemental Executive Retirement Plan (SERP) Restricted Stock | | | Fixed compensation awarded under the 2014 Omnibus Plan (the number of shares of Common Stock is determined formulaically and is dependent upon compensation, the stock price, the pension formula and actuarial assumptions) | | | Provides stock-based supplemental retirement benefits to named executive officers whose retirement plan benefits may be limited under applicable law | | |||
| Variable | | | Annual Cash Incentive Compensation | | | Variable, performance-based compensation, awarded under the Incentive Compensation Plan | | | Motivate and reward named executive officers for achieving annual business objectives based on Company performance and individual achievements | |
| Equity Compensation — Performance Earned Restricted Stock (PERS) | | | Variable, performance-based compensation, awarded under the 2014 Omnibus Plan (annual performance period) | | | Motivate and reward named executive officers for achieving annual business objectives; the threshold, target and maximum number of and performance goals for the award of PERS for a given fiscal year are set in July of that year; PERS are single-year performance awards | | |||
| Equity Compensation — Performance Stock Units (PSUs) | | | Variable, performance-based compensation, awarded under the 2014 Omnibus Plan (three-year performance period) | | | Motivate and reward named executive officers for achieving long-term, multi-year business objectives | | |||
| Equity Compensation — Stock Appreciation Rights (SARs) | | | Variable, awarded under the 2014 Omnibus Plan | | | Motivate and reward named executive officers for achieving long-term business objectives by tying incentives to the performance of our Common Stock | |
40 | | | 2024 Proxy Statement | | |
| Performance Metric | | | Why it is Important to Us | |
| Sales/Revenue Growth | | | Growth at or above market is indicative of innovation, level of service and cost competitiveness, all of which are critical to success in the marketplace. | |
| Adjusted EBIT Margin % | | | This metric is indicative of relative perceived value with higher relative margin implying higher value added in the marketplace. Additionally, increased margin expansion generates increased cash flow from the same amount of revenue. | |
| Working Capital as a % of Sales | | | Working Capital is the largest controllable asset on the Company’s balance sheet. Improvement in this metric drives meaningful improvement in cash generation. | |
| Gross Profit Margin | | | Gross profit measures profit after accounting for cost of goods sold and can help measure business efficiencies. | |
• | benchmarks versus the Compensation Peer Group; |
• | economic conditions; and |
• | overall financial performance of the Company, with a focus on the Key Financial Performance Metrics set forth in the preceding table. |
| | | Named Executive Officer Base Salary Amounts | | |||||||
| | | Fiscal 2025 | | | Fiscal 2024 | | | Fiscal 2023 | | |
| Frank C. Sullivan | | | $1,100,000 | | | $1,065,000 | | | $995,000 | |
| Russell L. Gordon | | | $595,000 | | | $575,000 | | | $535,000 | |
| Edward W. Moore | | | $470,000 | | | $455,000 | | | $425,000 | |
| Janeen B. Kastner | | | $460,000 | | | $445,000 | | | $415,000 | |
| Timothy R. Kinser | | | $450,000 | | | $420,000 | | | $400,000 | |
| | 2024 Proxy Statement | | | 41 |
42 | | | 2024 Proxy Statement | | |
• | Gross Profit Margin Improvement – A threshold of 12.5% of his or her target award could be earned for gross profit margin improvement relative to prior year and industry peers; target of 50% of his or her target award could be earned based on achievement of gross profit margin of 39.6%; and a maximum of 62.5% of his or her target award could be earned based on achievement of gross profit margin of 41.2%. Gross profit margin percentage improved from 38.0% in fiscal 2023 to 41.1% in fiscal 2024. As a result, the Compensation Committee elected to award 56.5% of the each named executive officer’s target award for this metric; |
• | Sales Growth Improvement – Up to 50% of his or her target award could be earned related to sales growth improvement relative to prior year and industry peers. The Company’s sales growth was 1.1% for fiscal 2024. As a result, the Compensation Committee elected to award 25.0% of the each named executive officer’s target award for this metric; and |
| | 2024 Proxy Statement | | | 43 |
• | Achievement of Company Initiatives and Individual Goals – Up to 50% of his or her target award could be earned relating to progress toward initiatives including MAP 2025 and Commercial Success (“CS-168”), ESG initiatives and achievement of individually assigned goals based on areas of responsibility. For fiscal 2024, the Company made significant progress toward MAP 2025 goals and CS-168. Each of the named executive officers contributed to these initiatives, as well as other prescribed goals and initiatives. As a result, the Compensation Committee elected to award 37.5% of each named executive officer’s target award except for Mr. Kinser. Because of his high level of individual involvement related to MAP 2025, the Compensation Committee awarded Mr. Kinser with 43.5% of his target award for this metric. |
• | to reward past performance; |
• | to incentivize future performance (both short-term and long-term); |
• | to align executives’ long-term interest with that of the stockholders; and |
• | to enhance the longer-term performance and profitability of the Company. |
44 | | | 2024 Proxy Statement | | |
| Performance Goal | | | Weight | | | Threshold 25% of Target | | | Target 100% | | | Maximum 125% of Target | | | Results | | | No of Target Vesting | |
| EBIT Margin | | | 50% | | | 11.6% | | | 13.2% | | | 15% | | | 12.8% | | | 87.5% | |
| Working Capital Ratio | | | 50% | | | 25% | | | 23% | | | 21% | | | 23.6% | | | 82.5% | |
| Results between levels are interpolated | | | | | | | | | | | Total Vesting | | | 85% | |
| | | Adjusted EBIT Margin(1) | | | Adjusted Revenue Growth(2) | | | % of Target Vesting | | |
| Weighting | | | 50% | | | 50% | | | | |
| Threshold | | | 14.0% | | | 3.0% | | | 25% | |
| Target | | | 16.0% | | | 5.0% | | | 100% | |
| Maximum | | | 18.0% | | | 7.0% | | | 200% | |
(1) | Measured at the end of the three-year performance period. |
(2) | Measured based on three-year compound annualized growth rate. |
| | 2024 Proxy Statement | | | 45 |
| Performance Goal | | | Threshold | | | Target | | | Maximum | | | Results | | | % of Target Vesting | |
| Adjusted EBIT Margin(1) | | | 13.0% | | | 15.0% | | | 17.0% | | | 12.8% | | | 0% | |
| Adjusted Revenue Growth(2) | | | 4.0% | | | 6.0% | | | 8.0% | | | 6.3% | | | 115% | |
| Results Between Levels are Interpolated | | | | | | | | | Total Vested | | | 57.5% | |
(1) | Measured at the end of the three-year performance period. |
(2) | Measured based on three-year compound annualized growth rate. ARG targets for the fiscal 2022 PSUs were set in July 2021 during the Covid pandemic when there was considerable uncertainty as to future revenue gains. |
• | for the Company’s Chief Executive Officer, Common Stock equivalent to seven times annual base salary; and |
• | for other executive officers of the Company, Common Stock equivalent to five times annual base salary. |
• | Frank C. Sullivan. Pursuant to an employment agreement whereby Mr. Sullivan serves as our Chair, President and Chief Executive Officer, Mr. Sullivan is entitled to an annual base salary of not less than $1,100,000 effective as of June 1, 2024. |
• | Russell L. Gordon. Pursuant to an employment agreement whereby Mr. Gordon serves as our Vice President and Chief Financial Officer, Mr. Gordon is entitled to an annual base salary of not less than $595,000 effective as of June 1, 2024. |
46 | | | 2024 Proxy Statement | | |
• | Edward W. Moore. Pursuant to an employment agreement whereby Mr. Moore serves as our Senior Vice President, General Counsel, Chief Compliance Officer and Secretary, Mr. Moore is entitled to an annual base salary of not less than $470,000 effective as of June 1, 2024. |
• | Janeen B. Kastner. Pursuant to an employment agreement whereby Ms. Kastner serves as our Vice President–Corporate Benefits and Risk Management, Ms. Kastner is entitled to an annual base salary of not less than $460,000 effective as of June 1, 2024. |
• | Timothy R. Kinser. Pursuant to an employment agreement whereby Mr. Kinser serves as our Vice President–Operations, Mr. Kinser is entitled to an annual base salary of not less than $450,000 effective as of June 1, 2024. |
• | the amount of the bonus, incentive compensation or stock award was calculated based upon the achievement of certain financial results that were subsequently the subject of a restatement, |
| | 2024 Proxy Statement | | | 47 |
• | the amount of the bonus, incentive compensation or stock award that would have been awarded to the executive officer had the financial results been properly reported would have been lower than the amount actually awarded, and |
• | it is reasonable to do so (e.g., the expense of recovering the compensation does not exceed the amount recovered). |
48 | | | 2024 Proxy Statement | | |
| | 2024 Proxy Statement | | | 49 |
| Name and Principal Position (a) | | | Year (b) | | | Salary ($) (c) | | | Bonus ($)(1) (d) | | | Stock Awards ($)(2)(3) (e) | | | Option Awards ($)(2)(3) (f) | | | Non-Equity Incentive Plan Compensation ($)(4) (g) | | | Change in Pension Value and Nonqualified Deferred Compensation Earnings ($)(5) (h) | | | All Other Compensation ($)(6) (i) | | | Total ($) (j) | |
| Frank C. Sullivan Chair, President and Chief Executive Officer | | | 2024 | | | 1,065,000 | | | 0 | | | 5,742,634 | | | 3,029,040 | | | 1,580,000 | | | 75,246 | | | 250,544 | | | 11,742,464 | |
| 2023 | | | 995,000 | | | 0 | | | 4,010,379 | | | 0 | | | 1,120,000 | | | 46,539 | | | 237,957 | | | 6,409,875 | | |||
| 2022 | | | 995,000 | | | 0 | | | 3,219,192 | | | 3,618,000 | | | 995,000 | | | 0 | | | 226,387 | | | 9,053,579 | | |||
| Russell L. Gordon Vice President and Chief Financial Officer | | | 2024 | | | 575,000 | | | 0 | | | 1,096,494 | | | 500,032 | | | 685,000 | | | 67,366 | | | 67,355 | | | 2,991,247 | |
| 2023 | | | 535,000 | | | 0 | | | 999,470 | | | 0 | | | 482,000 | | | 26,489 | | | 60,590 | | | 2,103,549 | | |||
| 2022 | | | 510,000 | | | 0 | | | 808,188 | | | 361,800 | | | 460,000 | | | 0 | | | 51,783 | | | 2,191,771 | | |||
| Edward W. Moore Senior Vice President, General Counsel and Chief Compliance Officer | | | 2024 | | | 455,000 | | | 0 | | | 952,395 | | | 500,032 | | | 540,000 | | | 19,554 | | | 209,613 | | | 2,676,594 | |
| 2023 | | | 425,000 | | | 0 | | | 865,318 | | | 0 | | | 383,000 | | | 0 | | | 188,141 | | | 1,861,459 | | |||
| 2022 | | | 400,000 | | | 0 | | | 666,232 | | | 361,800 | | | 360,000 | | | 0 | | | 139,464 | | | 1,927,496 | | |||
| Janeen B. Kastner Vice President – Corporate Benefits and Risk Management | | | 2024 | | | 445,000 | | | 0 | | | 1,107,528 | | | 500,032 | | | 530,000 | | | 62,158 | | | 54,106 | | | 2,698,824 | |
| 2023 | | | 415,000 | | | 0 | | | 996,392 | | | 0 | | | 374,000 | | | 22,290 | | | 52,906 | | | 1,861,218 | | |||
| 2022 | | | 385,000 | | | 0 | | | 771,591 | | | 361,800 | | | 347,000 | | | 0 | | | 49,699 | | | 1,915,090 | | |||
| Timothy R. Kinser Vice President – Operations | | | 2024 | | | 420,000 | | | 0 | | | 1,046,934 | | | 500,032 | | | 525,000 | | | 56,490 | | | 30,975 | | | 2,579,431 | |
| 2023 | | | 400,000 | | | 0 | | | 922,592 | | | 0 | | | 360,000 | | | 41,326 | | | 37,026 | | | 1,760,944 | | |||
| 2022 | | | 361,250 | | | 0 | | | 287,912 | | | 361,800 | | | 330,000 | | | 0 | | | 36,910 | | | 1,377,872 | |
(1) | Amounts earned under the Incentive Plan are reported in the Non-Equity Incentive Plan Compensation column. |
(2) | The dollar value of restricted stock and SARs set forth in these columns is equal to the fair market value as of the date of the respective grant. |
(3) | The Grants of Plan-Based Awards for Fiscal 2024 table sets forth the aggregate grant date fair value of the restricted stock granted during fiscal 2024 computed in accordance with ASC 718. Shares of restricted stock are subject to risk of forfeiture. |
(4) | The amounts set forth in this column were earned during fiscal 2024 and paid in July 2024, earned during fiscal 2023 and paid in July 2023 and earned during fiscal 2022 and paid in July 2022 for 2024, 2023 and 2022, respectively, under our Incentive Plan. |
(5) | The amounts set forth in this column reflect the change in present value of the executive officer’s accumulated benefits under the RPM International Inc. Retirement Plan (the “Retirement Plan”). During 2024, 2023 and 2022, there were no above-market or preferential earnings on nonqualified deferred compensation. The increase in present values is due to the increase in accrued benefit from the prior year as well as the discounting time period. These are partially offset by the increase in discount rate and the increase in short-term lump sum interest rates. |
(6) | All Other Compensation includes Company contributions to the 401(k) plan, life insurance premiums, automobile allowances, financial/estate planning, periodic executive physical examinations and charitable matching programs. For each named executive officer for whom the total value of all personal benefits exceed $10,000 in fiscal 2024, the amount of incremental cost to the Company for each personal benefit listed below, if applicable and to the extent such cost exceeded the greater of $25,000 or 10% of the total personal benefits for such named executive officer is as follows: life insurance premiums: Mr. Sullivan $192,905, Mr. Moore $140,961 and Mr. Gordon $26,317; and leased automobile: Mr. Sullivan $26,089 and Mr. Moore $26,868. Life insurance coverage amounts have not changed for these named executive officers. However, as each named executive officer ages, life insurance premiums increase. |
50 | | | 2024 Proxy Statement | | |
| | | | | Estimated Possible Payouts Under Non-Equity Incentive Plan Awards(1) | | | Estimated Possible Payouts Under Equity Incentive Plan Awards | | | All Other Stock Awards: Number of Shares of Stock or Units (#) (i) | | | All Other Option Awards: Number of Securities Underlying Options (#) (j) | | | Exercise or Base Price of Option Awards ($/Sh) (k) | | | Grant Date Fair Value of Stock and Option Awards ($)(2) (I) | | ||||||||||||||
| Name (a) | | | Grant Date (b) | | | Threshold ($) (c) | | | Target ($) (d) | | | Maximum ($) (e) | | | Threshold (#) (f) | | | Target (#) (g) | | | Maximum (#) (h) | | ||||||||||||
| Frank C. Sullivan | | | Incentive Plan Award | | | | | 1,331,250 | | | 2,000,000 | | | | | | | | | | | | | | | | ||||||||
| 7/18/24 PERS(4) | | | | | | | | | 6,550 | | | 13,100 | | | 16,375 | | | 11,140 | | | | | | | 1,272,856 | | ||||||||
| 7/19/23 PSUs(5) | | | | | | | | | | | | | | | 47,800 | | | | | | | 4,469,778 | | |||||||||||
| 7/19/23 SARs(6) | | | | | | | | | | | | | | | | | 126,000 | | | $93.51 | | | 3,029,040 | | ||||||||||
| Russell L. Gordon | | | 7/19/23 SERP Restricted Stock(3) | | | | | | | | | | | | | | | 1,541 | | | | | | | 144,099 | | ||||||||
| Incentive Plan Award | | | | | 575,000 | | | 862,500 | | | | | | | | | | | | | | | | |||||||||||
| 7/18/24 PERS(4) | | | | | | | | | 1,100 | | | 2,200 | | | 2,750 | | | 1,870 | | | | | | | 213,666 | | ||||||||
| 7/19/23 PSUs(5) | | | | | | | | | | | | | | | 7,900 | | | | | | | 738,729 | | |||||||||||
| 7/19/23 SARs(6) | | | | | | | | | | | | | | | | | 20,800 | | | $93.51 | | | 500,032 | | ||||||||||
| Edward W. Moore | | | Incentive Plan Award | | | | | 455,000 | | | 682,500 | | | | | | | | | | | | | | | | ||||||||
| 7/18/24 PERS(4) | | | | | | | | | 1,100 | | | 2,200 | | | 2,750 | | | 1,870 | | | | | | | 213,666 | | ||||||||
| 7/19/23 PSUs(5) | | | | | | | | | | | | | | | 7,900 | | | | | | | 738,729 | | |||||||||||
| 7/19/23 SARs(6) | | | | | | | | | | | | | | | | | 20,800 | | | $93.51 | | | 500,032 | | ||||||||||
| Janeen B. Kastner | | | 7/19/23 SERP Restricted Stock(3) | | | | | | | | | | | | | | | 1,659 | | | | | | | 155,133 | | ||||||||
| Incentive Plan Award | | | | | 445,000 | | | 667,500 | | | | | | | | | | | | | | | | |||||||||||
| 7/18/24 PERS(4) | | | | | | | | | 1,100 | | | 2,200 | | | 2,750 | | | 1,870 | | | | | | | 213,666 | | ||||||||
| 7/19/23 PSUs(5) | | | | | | | | | | | | | | | 7,900 | | | | | | | 738,729 | | |||||||||||
| 7/19/23 SARs(6) | | | | | | | | | | | | | | | | | 20,800 | | | $93.51 | | | 500,032 | | ||||||||||
| Timothy R. Kinser | | | 7/19/23 SERP Restricted Stock(3) | | | | | | | | | | | | | | | 1,011 | | | | | | | 94,539 | | ||||||||
| Incentive Plan Award | | | | | 420,000 | | | 630,000 | | | | | | | | | | | | | | | | |||||||||||
| 7/18/24 PERS(4) | | | | | | | | | 1,100 | | | 2,200 | | | 2,750 | | | 1,870 | | | | | | | 213,666 | | ||||||||
| 7/19/23 PSUs(5) | | | | | | | | | | | | | | | 7,900 | | | | | | | 738,729 | | |||||||||||
| 7/19/23 SARs(6) | | | | | | | | | | | | | | | | | 20,800 | | | $93.51 | | | 500,032 | |
(1) | These columns show the possible payouts for each named executive officer under the Incentive Plan for fiscal 2024 based on the goals set in early fiscal 2024. Detail regarding actual awards under the Incentive Plan is reported in the Summary Compensation Table and is included in the Compensation Discussion and Analysis. |
(2) | The values included in this column represent the grant date fair value of restricted stock computed in accordance with ASC 718, except no assumptions for forfeitures were included. A discussion of the assumptions used in calculating the compensation cost is set forth in Note J of the Notes to Consolidated Financial Statements of our 2024 Annual Report on Form 10-K. |
| | 2024 Proxy Statement | | | 51 |
(3) | Shares of SERP restricted stock awarded under the 2014 Omnibus Plan. These shares vest on the earliest to occur of (a) the later of either the employee’s attainment of age 55 or the fifth anniversary of the May 31st immediately preceding the date on which the shares of restricted stock were awarded, (b) the retirement of the employee on or after the attainment of age 65 or (c) a change in control with respect to the Company. |
(4) | PERS for which the threshold, target and maximum number of shares and performance goals with respect to fiscal 2024 were determined in early fiscal 2024 and are disclosed herein pursuant to Commission rules. Columns (i) and (l) show PERS actually awarded (number and value, respectively) as further described on pages 44 and 45 of this Proxy Statement. |
(5) | PSU awards were made pursuant to the 2014 Omnibus Plan and are contingent upon the level of attainment of performance goals for the three-year period from June 1, 2023 ending May 31, 2026. The determination of whether and to what extent the PSU awards are achieved for such period will be made following the close of fiscal year 2026. The amounts set forth in columns (i) and (l) assume the target amount of PSUs is awarded. |
(6) | SARs granted pursuant to the 2014 Omnibus Plan. These SARs vest in four equal installments, beginning July 19, 2024. |
• | As of May 31, 2022, the mortality table used was the Pri-2012 no-collar retiree generational mortality table for males and females with mortality improvements projected using Scale MP-2021, and the interest rate used to determine the present values was 4.44%. |
52 | | | 2024 Proxy Statement | | |
• | As of May 31, 2023, the mortality table used was the Pri-2012 no-collar retiree generational mortality table for males and females with mortality improvements projected using Scale MP-2021, and the interest rate used to determine the present values was 5.26%. |
• | As of May 31, 2024, the mortality table used was the Pri-2012 no-collar retiree generational mortality table for males and females with mortality improvements projected using Scale MP-2021, and the interest rate used to determine the present values was 5.58%. |
• | As of May 31, 2022, the mortality table used was the applicable mortality table outline in IRC Section 417(e) projected to 2031 using Scale MP-2020, and the interest rate used to determine the present values was 4.44%. |
• | As of May 31, 2023, the mortality table used was the applicable mortality table outline in IRC Section 417(e) projected to 2032 using Scale MP-2021, and the interest rate used to determine the present values was 5.26%. |
• | As of May 31, 2024, the mortality table used was the applicable mortality table outline in IRC Section 417(e) projected to 2032 using Scale MP-2021, and the interest rate used to determine the present values was 5.58%. |
• | As of May 31, 2022, the mortality table used was the applicable mortality table outlined in Internal Revenue Code Section 417(e) projected to 2031 using scale MP-2020. The interest rates used to determine the present values at normal retirement date were the April 2022 segment rates (3.00% for the first five years, 4.22% for the next 15 years and 4.17% thereafter) phased in over five years to the long term expected lump sum segment rates (3.55% for the first five years, 4.07% for the next 15 years and 4.37% thereafter). The lump sum present value was then discounted back to May 31, 2022 using 4.44%. |
• | As of May 31, 2023, the mortality table used was the applicable mortality table outlined in Internal Revenue Code Section 417(e) projected to 2031 using scale MP-2021. The interest rates used to determine the present values at normal retirement date were the April 2023 segment rates (4.77% for the first five years, 4.97% for the next 15 years and 5.13% thereafter) phased in over five years to the long term expected lump sum segment rates (3.55% for the first five years, 4.07% for the next 15 years, and 4.37% thereafter). The lump sum present value was then discounted back to May 31, 2023 using 5.26%. |
• | As of As of May 31, 2024, the mortality table used was the applicable mortality table outlined in Internal Revenue Code Section 417(e) projected to 2032 using scale MP-2021. The interest rates used to determine the present values at normal retirement date were the April 2024 segment rates (5.24% for the first five years, 5.48% for the next 15 years and 5.61% thereafter) phased in over five years to the long term expected lump sum segment rates (3.55% for the first five years, 4.07% for the next 15 years, and 4.37% thereafter). The lump sum present value was then discounted back to May 31, 2024 using 5.58%. |
| | 2024 Proxy Statement | | | 53 |
| | | Option Awards | | | Stock Awards | | ||||||||||||||||||||||
| Name (a) | | | Number of Securities Underlying Unexercised Options (#) Exercisable (b) | | | Number of Securities Underlying Unexercised Options (#) Unexercisable (c) | | | Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#) (d) | | | Option Exercise Price ($) (e) | | | Option Expiration Date (f) | | | Number of Shares or Units of Stock That Have Not Vested (#) (g) | | | Market Value of Shares or Units of Stock That Have Not Vested ($)(1) (h) | | | Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#)(2) (i) | | | Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($)(3) (j) | |
| Frank C. Sullivan | | | | | | | | | | | | | | | | | | | | |||||||||
| SERP | | | | | | | | | | | | | 1,844(4) | | | 206,712 | | | | | | |||||||
| PERS | | | | | | | | | | | | | 31,550(5) | | | 3,536,755 | | | | | | |||||||
| PERS | | | | | | | | | | | | | | | | | 16,375(6) | | | 1,835,638(6) | | |||||||
| PSUs | | | | | | | | | | | | | | | | | 241,200(7) | | | 27,038,520(7) | | |||||||
| SARs | | | 210,000 | | | 0 | | | | | 60.0100 | | | 7/16/2028 | | | | | | | | | | |||||
| 200,000 | | | 0 | | | | | 62.1700 | | | 7/18/2029 | | | | | | | | | | ||||||||
| 150,000 | | | 50,000(8) | | | | | 78.4900 | | | 7/22/2030 | | | | | | | | | | ||||||||
| 100,000 | | | 100,000(9) | | | | | 86.9300 | | | 7/21/2031 | | | | | | | | | | ||||||||
| 50,000 | | | 150,000(10) | | | | | 81.0100 | | | 7/18/2032 | | | | | | | | | | ||||||||
| 0 | | | 126,000(11) | | | | | 93.5100 | | | 7/19/2033 | | | | | | | | | | ||||||||
| Russell L. Gordon | | | | | | | | | | | | | | | | | | | | |||||||||
| SERP | | | | | | | | | | | | | 8,557(12) | | | 959,240 | | | | | | |||||||
| PERS | | | | | | | | | | | | | 8,100(13) | | | 908,010 | | | | | | |||||||
| PERS | | | | | | | | | | | | | | | | | 2,750(6) | | | 308,275(6) | | |||||||
| PSUs | | | | | | | | | | | | | | | | | 45,000(7) | | | 5,044,500(7) | |
54 | | | 2024 Proxy Statement | | |
| | | Option Awards | | | Stock Awards | | ||||||||||||||||||||||
| Name (a) | | | Number of Securities Underlying Unexercised Options (#) Exercisable (b) | | | Number of Securities Underlying Unexercised Options (#) Unexercisable (c) | | | Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#) (d) | | | Option Exercise Price ($) (e) | | | Option Expiration Date (f) | | | Number of Shares or Units of Stock That Have Not Vested (#) (g) | | | Market Value of Shares or Units of Stock That Have Not Vested ($)(1) (h) | | | Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#)(2) (i) | | | Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($)(3) (j) | |
| Russell L. Gordon (continued) SARs | | | 30,000 | | | 0 | | | | | 47.1400 | | | 7/20/2025 | | | | | | | | | | |||||
| 30,000 | | | 0 | | | | | 50.9900 | | | 7/25/2026 | | | | | | | | | | ||||||||
| 30,000 | | | 0 | | | | | 55.1900 | | | 7/17/2027 | | | | | | | | | | ||||||||
| 30,000 | | | 0 | | | | | 60.0100 | | | 7/16/2028 | | | | | | | | | | ||||||||
| 20,000 | | | 0 | | | | | 62.1700 | | | 7/18/2029 | | | | | | | | | | ||||||||
| 15,000 | | | 5,000(8) | | | | | 78.4900 | | | 7/22/2030 | | | | | | | | | | ||||||||
| 10,000 | | | 10,000(9) | | | | | 86.9300 | | | 7/21/2031 | | | | | | | | | | ||||||||
| 5,000 | | | 15,000(10) | | | | | 81.0100 | | | 7/18/2032 | | | | | | | | | | ||||||||
| 0 | | | 20,800(11) | | | | | 93.5100 | | | 7/19/2033 | | | | | | | | | | ||||||||
| Edward W. Moore | | | | | | | | | | | | | | | | | | | | |||||||||
| SERP | | | | | | | | | | | | | 1,025(14) | | | 114,903 | | | | | | |||||||
| PERS | | | | | | | | | | | | | 8,100(15) | | | 908,010 | | | | | | |||||||
| PERS | | | | | | | | | | | | | | | | | 2,750(6) | | | 308,275(6) | | |||||||
| PSUs | | | | | | | | | | | | | | | | | 45,000(7) | | | 5,044,500(7) | | |||||||
| SARs | | | 0 | | | 5,000(8) | | | | | 78.4900 | | | 7/22/2030 | | | | | | | | | | |||||
| 0 | | | 10,000(9) | | | | | 86.9300 | | | 7/21/2031 | | | | | | | | | | ||||||||
| 0 | | | 15,000(10) | | | | | 81.0100 | | | 7/18/2032 | | | | | | | | | | ||||||||
| 0 | | | 20,800(11) | | | | | 93.5100 | | | 7/19/2033 | | | | | | | | | | ||||||||
| Janeen B. Kastner | | | | | | | | | | | | | | | | | | | | |||||||||
| SERP | | | | | | | | | | | | | 7,669(16) | | | 859,695 | | | | | | |||||||
| PERS | | | | | | | | | | | | | 8,100(17) | | | 908,010 | | | | | | |||||||
| PERS | | | | | | | | | | | | | | | | | 2,750(6) | | | 308,275(6) | | |||||||
| PSUs | | | | | | | | | | | | | | | | | 45,000(7) | | | 5,044,500(7) | |
| | 2024 Proxy Statement | | | 55 |
| | | Option Awards | | | Stock Awards | | ||||||||||||||||||||||
| Name (a) | | | Number of Securities Underlying Unexercised Options (#) Exercisable (b) | | | Number of Securities Underlying Unexercised Options (#) Unexercisable (c) | | | Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#) (d) | | | Option Exercise Price ($) (e) | | | Option Expiration Date (f) | | | Number of Shares or Units of Stock That Have Not Vested (#) (g) | | | Market Value of Shares or Units of Stock That Have Not Vested ($)(1) (h) | | | Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#)(2) (i) | | | Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($)(3) (j) | |
| Janeen B. Kastner (continued) SARs | | | 30,000 | | | 0 | | | | | 50.9900 | | | 7/25/2026 | | | | | | | | | | |||||
| 30,000 | | | 0 | | | | | 55.1900 | | | 7/17/2027 | | | | | | | | | | ||||||||
| 30,000 | | | 0 | | | | | 60.0100 | | | 7/16/2028 | | | | | | | | | | ||||||||
| 20,000 | | | 0 | | | | | 62.1700 | | | 7/18/2029 | | | | | | | | | | ||||||||
| 15,000 | | | 5,000(8) | | | | | 78.4900 | | | 7/22/2030 | | | | | | | | | | ||||||||
| 10,000 | | | 10,000(9) | | | | | 86.9300 | | | 7/21/2031 | | | | | | | | | | ||||||||
| 5,000 | | | 15,000(10) | | | | | 81.0100 | | | 7/18/2032 | | | | | | | | | | ||||||||
| 0 | | | 20,800(11) | | | | | 93.5100 | | | 7/19/2033 | | | | | | | | | | ||||||||
| Timothy R. Kinser | | | | | | | | | | | | | | | | | | | | |||||||||
| SERP | | | | | | | | | | | | | 3,205(18) | | | 359,281 | | | | | | |||||||
| PERS | | | | | | | | | | | | | 6,300(19) | | | 706,230 | | | | | | |||||||
| PERS | | | | | | | | | | | | | | | | | 2,750(6) | | | 308,275(6) | | |||||||
| PSUs | | | | | | | | | | | | | | | | | 36,200(7) | | | 4,058,020(7) | | |||||||
| SARs | | | 5,000 | | | 15,000(10) | | | | | 81.0100 | | | 7/18/2032 | | | | | | | | | | |||||
| 0 | | | 20,800(11) | | | | | 93.5100 | | | 7/19/2033 | | | | | | | | | |
(1) | Market value of Common Stock reported in column (h) was calculated by multiplying $112.10, the closing market price of the Company’s Common Stock on May 31, 2024, the last business day of fiscal 2024, by the number of shares. |
(2) | Represents the maximum number of shares that could be paid out. |
(3) | Market value of equity incentive awards of stock reported in column (j) was calculated by multiplying the closing market price of the Company’s Common Stock on May 31, 2024, the last business day of fiscal 2024, by the maximum number of shares that could be paid out. |
(4) | These shares of SERP restricted stock vest on the fifth anniversary of the May 31st immediately preceding the date on which each grant of restricted stock was made. These shares could vest earlier upon the death or disability of Mr. Sullivan, upon termination without cause, or upon a change of control of the Company prior to those dates. |
(5) | These PERS vest according to the following schedule: 21,150 on July 21, 2024 and 10,400 on July 19, 2026. |
(6) | In early fiscal 2023, the Compensation Committee determined the maximum number of and performance goals for the award of PERS with respect to fiscal 2024. Market value reported in column (j) was calculated by multiplying the closing market price of the Company’s Common Stock on May 31, 2024 by the estimated number of shares in column (i). |
(7) | The PSU awards were made pursuant to the 2014 Omnibus Plan and are contingent upon the level of attainment of performance goals for the three-year period from June 1, 2021 ending May 31, 2024, the three-year period from June 1, 2022 ending May 31, 2025 and the three-year period from June 1, 2023 ending May 31, 2026. The determination of whether and to what extent the PSU awards are achieved will be made following the close of fiscal year 2024, fiscal year 2025 and fiscal year 2026, respectively. The amounts set forth in columns (i) and (j) assume the maximum amount of PSUs are awarded. |
56 | | | 2024 Proxy Statement | | |
(8) | These SARs become exercisable on July 22, 2024. |
(9) | These SARs become exercisable in two equal installments on July 21, 2024 and July 21, 2025. |
(10) | These SARs become exercisable in three equal installments on July 18, 2024, July 18, 2025 and July 18, 2026. |
(11) | These SARs become exercisable in four equal installments on July 19, 2024, July 19, 2025, July 19, 2026 and July 19, 2027. |
(12) | These shares of SERP restricted stock vest on the fifth anniversary of the May 31st immediately preceding the date on which each grant of restricted stock was made. These shares could vest earlier upon the death or disability of Mr. Gordon, upon termination without cause, or upon a change in control of the Company prior to that date. |
(13) | These PERS vest according to the following schedule: 5,400 shares on July 21, 2024 and 2,700 shares on July 19, 2026. |
(14) | These shares of SERP restricted stock vest on the fifth anniversary of the May 31st immediately preceding the date on which each grant of restricted stock was made. These shares could vest earlier upon the death or disability of Mr. Moore, upon termination without cause, or upon a change in control of the Company prior to those dates. |
(15) | These PERS vest according to the following schedule: 5,400 shares on July 21, 2024 and 2,700 shares on July 19, 2026. |
(16) | These shares of SERP restricted stock vest on the fifth anniversary of the May 31st immediately preceding the date on which each grant of restricted stock was made. These shares could vest earlier upon the death or disability of Ms. Kastner, upon termination without cause, or upon a change in control of the Company prior to that date. |
(17) | These PERS vest according to the following schedule: 5,400 shares on July 21, 2024 and 2,700 shares on July 19, 2026. |
(18) | These shares of SERP restricted stock vest on the fifth anniversary of the May 31st immediately preceding the date on which each grant of restricted stock was made. These shares could vest earlier upon the death or disability of Mr. Kinser, upon termination without cause, or upon a change in control of the Company prior to those dates. |
(19) | These PERS vest according to the following schedule: 3,600 shares on July 21, 2024 and 2,700 shares on July 19, 2026. |
| | | Option Awards | | | Stock Awards | | |||||||
| Name (a) | | | Number of Shares Acquired on Exercise (#) (b) | | | Value Realized on Exercise ($) (c) | | | Number of Shares Acquired on Vesting (#) (d) | | | Value Realized on Vesting ($) (e) | |
| Frank C. Sullivan | | | 400,000 | | | 18,580,000 | | | 68,000 | | | 6,348,600 | |
| Russell L. Gordon | | | 30,000 | | | 2,071,500 | | | 17,793 | | | 1,722,520 | |
| Edward W. Moore | | | 30,000 | | | 738,500 | | | 15,399 | | | 1,454,153 | |
| Janeen B. Kastner | | | 30,000 | | | 2,000,700 | | | 16,457 | | | 1,572,755 | |
| Timothy R. Kinser | | | 0 | | | 0 | | | 7,695 | | | 735,447 | |
| | 2024 Proxy Statement | | | 57 |
| Name (a) | | | Plan Name (b) | | | Number of Years Credited Service at Fiscal Year End (c) | | | Present Value of Accumulated Benefit ($) (d) | | | Payments During Last Fiscal Year ($) (e) | |
| Frank C. Sullivan | | | RPM International Inc. Retirement Plan | | | 35.3 | | | 1,219,734 | | | 0 | |
| Russell L. Gordon | | | RPM International Inc. Retirement Plan | | | 29.3 | | | 819,287 | | | 0 | |
| Edward W. Moore | | | RPM International Inc. Retirement Plan | | | 17.6 | | | 717,124 | | | 0 | |
| Janeen B. Kastner | | | RPM International Inc. Retirement Plan | | | 27.3 | | | 755,313 | | | 0 | |
| Timothy R. Kinser | | | RPM International Inc. Retirement Plan | | | 16.8 | | | 615,798 | | | 0 | |
58 | | | 2024 Proxy Statement | | |
| Name (a) | | | Executive Contributions in Last FY ($) (b) | | | Registrant Contributions in Last FY ($) (c) | | | Aggregate Earnings in Last FY ($)(1) (d) | | | Aggregate Withdrawals/ Distributions ($) (e) | | | Aggregate Balance at Last FYE ($) (f) | |
| Frank C. Sullivan | | | 0 | | | 0 | | | 0 | | | 0 | | | 0 | |
| Russell L. Gordon | | | 0 | | | 0 | | | 0 | | | 0 | | | 0 | |
| Edward W. Moore | | | 0 | | | 0 | | | 0 | | | 0 | | | 0 | |
| Janeen B. Kastner | | | 187,000 | | | 0 | | | 266,712 | | | 0 | | | 1,608,217 | |
| Timothy R. Kinser | | | 126,000 | | | 0 | | | 149,433 | | | 0 | | | 1,247,035 | |
(1) | None of the earnings in this column, if any, would be included in the Summary Compensation Table because they were not preferential or above market. |
| | 2024 Proxy Statement | | | 59 |
| Event | | | Frank C. Sullivan | | | Russell L. Gordon | | | Edward W. Moore | | | Janeen B. Kastner | | | Timothy R. Kinser | |
| Retirement | | | | | | | | | | | | |||||
| Accelerated SARs | | | $11,203,340 | | | $1,272,772 | | | $1,272,772 | | | $1,272,772 | | | $853,022 | |
| Accelerated PERS | | | 3,536,755 | | | 908,010 | | | 908,010 | | | 908,010 | | | 706,230 | |
| Accelerated SERP restricted stock | | | 0 | | | 0 | | | 114,903 | | | 0 | | | 0 | |
| Total | | | $14,740,095 | | | $2,180,782 | | | $2,295,685 | | | $2,180,782 | | | $1,559,252 | |
| Death | | | | | | | | | | | | |||||
| Earned incentive compensation | | | $1,580,000 | | | $542,333 | | | $427,667 | | | $417,000 | | | $405,000 | |
| Accelerated SARs | | | 11,203,340 | | | 1,272,772 | | | 1,272,772 | | | 1,272,772 | | | 853,022 | |
| Accelerated PERS | | | 3,536,755 | | | 908,010 | | | 908,010 | | | 908,010 | | | 706,230 | |
| Accelerated SERP restricted stock | | | 206,712 | | | 959,240 | | | 114,903 | | | 859,695 | | | 359,281 | |
| Total | | | $16,526,807 | | | $3,682,355 | | | $2,723,352 | | | $3,457,477 | | | $2,323,533 | |
| Disability | | | | | | | | | | | | |||||
| Earned incentive compensation | | | $1,580,000 | | | $542,333 | | | $427,667 | | | $417,000 | | | $405,000 | |
| Accelerated SARs | | | 11,203,340 | | | 1,272,772 | | | 1,272,772 | | | 1,272,772 | | | 853,022 | |
| Accelerated PERS | | | 3,536,755 | | | 908,010 | | | 908,010 | | | 908,010 | | | 706,230 | |
| Accelerated SERP restricted stock | | | 206,712 | | | 959,240 | | | 114,903 | | | 859,695 | | | 359,281 | |
| Total | | | $16,526,807 | | | $3,682,355 | | | $2,723,352 | | | $3,457,477 | | | $2,323,533 | |
| Voluntary Termination and Termination for Cause | | | | | | | | | | | | |||||
| No payments | | | N/A | | | N/A | | | N/A | | | N/A | | | N/A | |
| Total | | | $0 | | | $0 | | | $0 | | | $0 | | | $0 | |
| Involuntary Termination Without Cause and not within Two Years of a Change in Control | | | | | | | | | | | | |||||
| Lump sum | | | $7,935,000 | | | $1,404,833 | | | $1,337,667 | | | $1,084,500 | | | $1,035,000 | |
| Health and welfare benefits | | | 82,476 | | | 41,238 | | | 54,984 | | | 37,386 | | | 37,386 | |
| Estate and financial planning | | | 16,000 | | | 16,000 | | | 16,000 | | | 16,000 | | | 16,000 | |
| Executive life insurance coverage | | | 643,588 | | | 44,870 | | | 281,922 | | | 30,918 | | | 0 | |
| Cash value of SERP Grant | | | 0 | | | 259,119 | | | 0 | | | 278,961 | | | 170,000 | |
| Accelerated SERP restricted stock | | | 206,712 | | | 959,240 | | | 114,903 | | | 859,695 | | | 359,281 | |
| Total | | | $8,883,776 | | | $2,725,300 | | | $1,805,476 | | | $2,307,460 | | | $1,617,667 | |
| Involuntary Termination Without Cause or Resignation for Good Reason within Two Years of a Change in Control | | | | | | | | | | | | |||||
| Lump sum | | | $7,935,000 | | | $1,404,833 | | | $1,792,667 | | | $1,084,500 | | | $1,035,000 | |
| Health and welfare benefits | | | 82,476 | | | 41,238 | | | 82,476 | | | 37,386 | | | 37,386 | |
| Estate and financial planning | | | 32,000 | | | 16,000 | | | 32,000 | | | 16,000 | | | 16,000 | |
60 | | | 2024 Proxy Statement | | |
| Event | | | Frank C. Sullivan | | | Russell L. Gordon | | | Edward W. Moore | | | Janeen B. Kastner | | | Timothy R. Kinser | |
| Executive life insurance coverage | | | 1,105,764 | | | 77,091 | | | 726,566 | | | 53,120 | | | 0 | |
| Cash value of SERP Grant | | | 0 | | | 259,119 | | | 0 | | | 278,961 | | | 170,000 | |
| Accelerated SERP restricted stock | | | 206,712 | | | 959,240 | | | 114,903 | | | 859,695 | | | 359,281 | |
| Accelerated PSUs, PERS and SARs | | | 28,259,355 | | | 4,703,032 | | | 4,703,032 | | | 4,703,032 | | | 3,588,262 | |
| Outplacement assistance | | | 20,000 | | | 20,000 | | | 20,000 | | | 20,000 | | | 20,000 | |
| Excise taxes | | | 0 | | | 0 | | | 0 | | | 0 | | | 0 | |
| Total | | | $37,641,307 | | | $7,480,553 | | | $7,471,644 | | | $7,052,694 | | | $5,225,929 | |
| Change in Control Only | | | | | | | | | | | | |||||
| Accelerated SERP restricted stock | | | $206,712 | | | $959,240 | | | $114,903 | | | $859,695 | | | $0 | |
| Accelerated PSUs, PERS and SARs | | | 28,259,355 | | | 4,703,032 | | | 4,703,032 | | | 4,703,032 | | | 0 | |
| Excise taxes | | | 0 | | | 0 | | | 0 | | | 0 | | | 0 | |
| Total | | | $28,466,067 | | | $5,662,272 | | | $4,817,935 | | | $5,562,727 | | | $0 | |
| | 2024 Proxy Statement | | | 61 |
• | for Mr. Sullivan, a lump sum amount equal to his incentive compensation for the preceding fiscal year (if not yet paid) plus three times the sum of: (i) the greater of his annual base salary in effect on the date of termination or the highest base salary in effect at any time during the three years immediately preceding the termination date, and (ii) the highest annual incentive compensation received by Mr. Sullivan in the five years prior to the termination date. Messrs. Gordon, Moore and Kinser, and Ms. Kastner would be entitled to receive a lump sum amount equal to the executive’s incentive compensation for the preceding fiscal year (if not yet paid), plus the sum of (x) for Mr. Moore, two times, and for Messrs. Gordon and Kinser, and Ms. Kastner, one and one-half times the executive’s annual base salary in effect on the date of termination, and (y) a pro rata |
62 | | | 2024 Proxy Statement | | |
• | continuation of health and welfare benefits for three years for Mr. Sullivan, for two years for Mr. Moore, and for 18 months for Messrs. Gordon and Kinser, and Ms. Kastner; |
• | estate and financial planning services for a period of six months; |
• | a lump sum payment equal to three times, for Mr. Sullivan, two times, for Mr. Moore, and one and one-half times for Messrs. Gordon and Kinser, and Ms. Kastner, the most recent annual premium or other cost for the executive life insurance coverage in effect on the date of termination (or, if greater, the next scheduled annual premium shown on the then current schedule of coverage); |
• | a lump sum amount equal to the cash value of three years for Mr. Sullivan, two years for Mr. Moore, and 18 months for Messrs. Gordon and Kinser, and Ms. Kastner, of benefits that the executive would have received had he or she continued to participate and receive awards under the Restricted Stock Plan (as determined in accordance with the Company’s past practice); and |
• | the lapse of all transfer restrictions and forfeiture provisions on SERP restricted stock awarded under the Restricted Stock Plan and the 2014 Omnibus Plan. |
• | for Mr. Sullivan, a lump sum amount equal to his incentive compensation for the preceding fiscal year (if not yet paid) plus three times the sum of (i) the greater of his annual base salary in effect on the date of termination or the highest base salary in effect at any time during the three years immediately preceding the change in control, and (ii) the highest annual incentive compensation received by Mr. Sullivan in the five years prior to the change in control. Messrs. Gordon, Moore and Kinser, and Ms. Kastner would be entitled to receive a lump sum amount equal to the executive’s incentive compensation for the preceding fiscal year (if not yet paid), plus the sum of (x) for Mr. Moore, three times and for Messrs. Gordon and Kinser, and Ms. Kastner, one and one-half times the executive’s annual base salary in effect on the date of termination, and (y) a pro rata portion of the executive’s average incentive compensation for the three most recently completed fiscal years. The pro rata portion is determined by multiplying the average incentive compensation by a fraction, the numerator of which is the number of days in the current fiscal year of the Company that have expired prior to the termination date and the denominator of which is 365; |
• | continuation of health and welfare benefits for a period of three years for Messrs. Sullivan and Moore, and for a period of 18 months for Messrs. Gordon and Kinser, and Ms. Kastner; |
• | estate and financial planning services for a period of one year for Messrs. Sullivan and Moore, and for a period of 6 months for Messrs. Gordon and Kinser, and Ms. Kastner; |
• | a lump sum payment equal to, for Messrs. Sullivan and Moore, three times and for Messrs. Gordon and Kinser, and Ms. Kastner, one and one-half times the most recent annual premium or other cost for the executive life insurance coverage in effect on the date of termination, grossed up to compensate for the tax impact of the payment (or, if greater, the next scheduled annual premium payment shown on the then-current schedule of coverage); |
• | a lump sum amount equal to the cash value of, for Messrs. Sullivan and Moore, three years, and for Messrs. Gordon and Kinser, and Ms. Kastner, 18 months of benefits that the executive would have received had he or she continued to participate and received SERP awards (as determined in accordance with the Company’s past practice); |
• | the lapse of all transfer restrictions and forfeiture provisions on SERP restricted stock awards; |
| | 2024 Proxy Statement | | | 63 |
• | the lapse of transfer restrictions on any awards under the 2014 Omnibus Plan; |
• | outplacement assistance for two years following the change in control; |
• | For Messrs. Sullivan, Moore and Gordon and Ms. Kastner, a lump sum payment, or gross-up, equal to the amount of any excise tax imposed on the executive under Section 4999 of the Internal Revenue Code, or any similar state or local tax law, and any taxes, interest or penalties incurred with respect thereto; |
• | interest on certain of the above payments if not made in a timely manner in accordance with the employment agreement or change in control agreement; and |
• | up to an amount of $250,000 in legal fees incurred by the executive in each of the two calendar years following termination of employment in the event that, following a change in control, he or she may be caused to institute or defend legal proceedings to enforce his or her rights under the employment agreement or change in control agreement. |
64 | | | 2024 Proxy Statement | | |
| Fiscal Year (a) | | | Summary Compensation Table Total for PEO(1) (b) | | | Compensation Actually Paid to PEO(1)(2) (c) | | | Average Summary Compensation Table Total for non-PEO NEOs(1) (d) | | | Average Compensation Actually Paid to non-PEO NEOs(1)(2) (e) | | | Value of Initial Fixed $100 Investment Based on: | | | Net Income ($ millions) (h) | | | Adjusted EBIT Margin %(4) (i) | | |||
| Total Stockholder Return (f) | | | Peer Group Total Stockholder Return(3) (g) | | |||||||||||||||||||||
| 2024 | | | $ | | | $ | | | $ | | | $ | | | $ | | | $ | | | $ | | | | |
| 2023 | | | $ | | | $ | | | $ | | | $ | | | $ | | | $ | | | $ | | | | |
| 2022 | | | $ | | | $ | | | $ | | | $ | | | $ | | | $ | | | $ | | | | |
| 2021 | | | $ | | | $ | | | $ | | | $ | | | $ | | | $ | | | $ | | | |
(1) | The PEO for fiscal 2024, fiscal 2023, fiscal 2022 and fiscal 2021 was |
(2) | The following amounts were deducted from/added to Summary Compensation Table: total compensation in accordance with the Commission-mandated adjustments to calculate CAP to the Company’s PEO and average CAP to the Company’s non-PEO NEOs. The fair value of equity awards was determined using methodologies and assumptions developed in a manner substantively consistent with those used to determine the grant date fair value of such awards. |
| | 2024 Proxy Statement | | | 65 |
| Fiscal Year | | | 2024 | | | 2023 | | | 2022 | | | 2021 | |
| SCT Total | | | $ | | | $ | | | $ | | | $ | |
| Deduction for Amounts Reported in the “Stock Awards” and “Option Awards” columns in the SCT for Applicable Fiscal Year | | | ($ | | | ($ | | | ($ | | | ($ | |
| Increase in Fair Value of Awards Granted During Applicable Fiscal Year that Remain Unvested as of Applicable Fiscal Year-End, Determined as of Applicable Fiscal Year-End | | | $ | | | $ | | | $ | | | $ | |
| Increase in Fair Value of Awards Granted During Applicable Fiscal Year that Vested During Applicable Fiscal Year, Determined as of Vesting Date | | | $ | | | $ | | | $ | | | $ | |
| Change in Fair Value of Awards Granted During Prior Fiscal Year that were Outstanding and Unvested as of Applicable Fiscal Year-End, Determined Based on Change in Fair Value from Prior Fiscal Year-End to Applicable Fiscal Year-End | | | $ | | | ($ | | | ($ | | | $ | |
| Change in Fair Value of Awards Granted During Prior Fiscal Year that Vested During Applicable Fiscal Year, Determined Based on Change in Fair Value from Prior Fiscal Year-End to Vesting Date | | | ($ | | | ($ | | | ($ | | | $ | |
| Reduction of Fair Value of Awards Granted During Prior Fiscal Year that were Forfeited During Applicable Fiscal Year, Determined as of Prior Fiscal Year-End | | | $ | | | $ | | | $ | | | $ | |
| Increase Based on Dividends or Other Earnings Paid During Applicable Fiscal Year Prior to Vesting Date | | | $ | | | $ | | | $ | | | $ | |
| Increase Based on Incremental Fair Value of Options/SARs Modified During Applicable Fiscal Year | | | $ | | | $ | | | $ | | | $ | |
| Reduction for Values Reported in “Change in Pension Value and Nonqualified Deferred Compensation Earnings” Column of the SCT for Applicable Fiscal Year | | | ($ | | | ($ | | | $ | | | ($ | |
| Increase for Service Cost and, if Applicable, Prior Service Cost for Pension Plans | | | $ | | | $ | | | $ | | | $ | |
| Total Adjustments | | | $ | | | ($ | | | ($ | | | $ | |
| CAP | | | $ | | | $ | | | $ | | | $ | |
66 | | | 2024 Proxy Statement | | |
| Fiscal Year | | | 2024 | | | 2023 | | | 2022 | | | 2021 | |
| Average SCT Total | | | $ | | | $ | | | $ | | | $ | |
| Deduction for Amounts Reported in the “Stock Awards” and “Option Awards” columns in the SCT for Applicable Fiscal Year | | | ($ | | | ($ | | | ($ | | | ($ | |
| Increase in Fair Value of Awards Granted During Applicable Fiscal Year that Remain Unvested as of Applicable Fiscal Year-End, Determined as of Applicable Fiscal Year-End | | | $ | | | $ | | | $ | | | $ | |
| Increase in Fair Value of Awards Granted During Applicable Fiscal Year that Vested During Applicable Fiscal Year, Determined as of Vesting Date | | | $ | | | $ | | | $ | | | $ | |
| Change in Fair Value of Awards Granted During Prior Fiscal Year that were Outstanding and Unvested as of Applicable Fiscal Year-End, Determined Based on Change in Fair Value from Prior Fiscal Year-End to Applicable Fiscal Year-End | | | $ | | | ($ | | | ($ | | | $ | |
| Change in Fair Value of Awards Granted During Prior Fiscal Year that Vested During Applicable Fiscal Year, Determined Based on Change in Fair Value from Prior Fiscal Year-End to Vesting Date | | | ($ | | | ($ | | | ($ | | | $ | |
| Reduction of Fair Value of Awards Granted During Prior Fiscal Year that were Forfeited During Applicable Fiscal Year, Determined as of Prior Fiscal Year-End | | | $ | | | $ | | | ($ | | | $ | |
| Increase Based on Dividends or Other Earnings Paid During Applicable Fiscal Year Prior to Vesting Date | | | $ | | | $ | | | $ | | | $ | |
| Increase Based on Incremental Fair Value of Options/SARs Modified During Applicable Fiscal Year | | | $ | | | $ | | | $ | | | $ | |
| Reduction for Values Reported in “Change in Pension Value and Nonqualified Deferred Compensation Earnings” Column of the SCT for Applicable Fiscal Year | | | ($ | | | ($ | | | $ | | | ($ | |
| Increase for Service Cost and, if Applicable, Prior Service Cost for Pension Plans | | | $ | | | $ | | | $ | | | $ | |
| Total Adjustments | | | $ | | | ($ | | | ($ | | | $ | |
| Average CAP | | | $ | | | $ | | | $ | | | $ | |
(3) | The Peer Group Index is comprised of Akzo Nobel N.V., Axalta Coating Systems Ltd., Carlisle Companies Inc., H.B. Fuller Company, Masco Corporation, PPG Industries, Inc., The Sherwin-Williams Company and Sika AG. |
(4) |
| | 2024 Proxy Statement | | | 67 |
68 | | | 2024 Proxy Statement | | |
| Most Important Performance Measures | |
| • • • • | |
| | 2024 Proxy Statement | | | 69 |
| Name (a) | | | Fees Earned or Paid in Cash ($)(1) (b) | | | Stock Awards ($)(2) (c) | | | Option Awards ($) (d) | | | Non-Equity Incentive Plan Compensation ($) (e) | | | Change in Pension Value and Nonqualified Deferred Compensation Earnings ($) (f) | | | All Other Compensation ($) (g) | | | Total ($) (h) | |
| Kirkland B. Andrews | | | 100,000 | | | 177,498 | | | 0 | | | 0 | | | 0 | | | 0 | | | 277,498 | |
| John M. Ballbach | | | 100,000 | | | 177,498 | | | 0 | | | 0 | | | 0 | | | 0 | | | 277,498 | |
| Bruce A. Carbonari | | | 135,000 | | | 177,498 | | | 0 | | | 0 | | | 0 | | | 0 | | | 312,498 | |
| Jenniffer D. Deckard | | | 100,000 | | | 177,498 | | | 0 | | | 0 | | | 0 | | | 0 | | | 277,498 | |
| Salvatore D. Fazzolari | | | 120,000 | | | 177,498 | | | 0 | | | 0 | | | 0 | | | 2,500(3) | | | 299,998 | |
| Julie A. Lagacy(4) | | | 50,000 | | | 0 | | | 0 | | | 0 | | | 0 | | | 0 | | | 50,000 | |
| Robert A. Livingston | | | 120,000 | | | 177,498 | | | 0 | | | 0 | | | 0 | | | 0 | | | 297,498 | |
| Frederick R. Nance | | | 120,000 | | | 177,498 | | | 0 | | | 0 | | | 0 | | | 2,500(3) | | | 299,998 | |
| Ellen M. Pawlikowski | | | 100,000 | | | 177,498 | | | 0 | | | 0 | | | 0 | | | 2,500(3) | | | 279,998 | |
| William B. Summers, Jr. | | | 100,000 | | | 177,498 | | | 0 | | | 0 | | | 0 | | | 0 | | | 277,498 | |
| Elizabeth F. Whited | | | 100,000 | | | 177,498 | | | 0 | | | 0 | | | 0 | | | 0 | | | 277,498 | |
(1) | Cash fees include fees for attending Board and Committee meetings in fiscal 2024 as well as the quarterly retainer amount for serving on the Board of Directors and as the chair for a committee during fiscal 2024. |
(2) | The amounts set forth in this column reflect the fair market value of shares of restricted stock granted during fiscal 2024 under the 2014 Omnibus Plan. |
(3) | These amounts represent the dollar value that RPM matches of the Director’s charitable contributions made in accordance with our employee charitable contributions matching program. RPM matches a Director’s charitable contributions by up to $2,500 per year under this program, which is also available to RPM International Inc. employees. These amounts are not taxable to the Directors. |
(4) | Ms. Lagacy retired from the Board of Directors as of October 5, 2023. |
| Under the Company’s stock ownership guidelines for Directors, each Director who has served on the Board of Directors for at least five years is expected to own Common Stock with a value of at least five times the annual cash retainer for Directors. | |
70 | | | 2024 Proxy Statement | | |
| | 2024 Proxy Statement | | | 71 |
72 | | | 2024 Proxy Statement | | |
| Plan Category | | | Number of securities to be issued upon exercise of outstanding options, warrants and rights (a) | | | Weighted- average exercise price of outstanding options, warrants and rights (b) | | | Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) (c)(1) | |
| Equity compensation plans approved by stockholders | | | 0(2) | | | $0.00 | | | 3,024,465 | |
| Equity compensation plans not approved by stockholders(3) | | | — | | | — | | | — | |
| Total | | | 0 | | | $0.00 | | | 3,024,465 | |
(1) | All shares available for future issuance under the 2014 Omnibus Plan, of which 1,164,365 shares may be subject to full value awards such as restricted stock. |
(2) | At May 31, 2024, 1,989,900 SARs were outstanding at a weighted-average grant price of $75.54. The number of shares to be issued upon exercise will be determined at vesting based on the difference between the grant price and the market price at the date of exercise. No such shares have been included in this total. |
(3) | The Company does not maintain equity compensation plans that have not been approved by its stockholders. |
| | 2024 Proxy Statement | | | 73 |
Q: | WHAT IS THE 2024 OMNIBUS PLAN? |
A: | The 2024 Omnibus Plan will be the only stock-based award program for covered employees and Directors. The 2024 Omnibus Plan will provide the Company with the flexibility to grant a wide variety of stock and stock-based awards, as well as dollar-denominated performance-based awards. The 2024 Omnibus Plan will replace the Company’s current equity compensation plan, the RPM International Inc. 2014 Omnibus Equity and Incentive Plan (the “2014 Omnibus Plan”), which expires by its terms on October 9, 2024. |
Q: | WHAT AM I VOTING ON? |
A: | The Company is seeking approval by its stockholders of a proposal to approve and adopt the 2024 Omnibus Plan. The 2024 Omnibus Plan will allow the Company to issue up to 5,000,000 shares of Common Stock in the form of equity and equity-based compensation to certain eligible employees and Directors. |
Q: | HAS THE 2024 OMNIBUS PLAN BEEN APPROVED AND ADOPTED BY THE COMPANY’S BOARD OF DIRECTORS? |
A: | Yes, but subject to stockholder approval. The 2024 Omnibus Plan was approved by the Compensation Committee and further approved and adopted by the Board of Directors in July 2024, subject to stockholder approval. Under Commission and NYSE rules, the Company is required to submit the 2024 Omnibus Plan to a vote of the stockholders. |
Q: | WHY DID THE BOARD OF DIRECTORS APPROVE THE 2024 OMNIBUS PLAN? |
A: | The Board of Directors believes that stock-based and performance-based awards are an important component of the Company’s compensation programs. The 2024 Omnibus Plan will give the Compensation Committee, which administers the 2024 Omnibus Plan, the flexibility to grant a wide variety of either service-based or performance-based awards. Furthermore, the 2014 Omnibus Plan expires under its own terms on October 9, 2024. Therefore, the Board of Directors and the Compensation Committee approved the 2024 Omnibus Plan in order to provide access to a new pool of equity awards. The goal of the 2024 Omnibus Plan is to make the most appropriate award depending upon various factors and to promote the interests of the Company and its stockholders by attracting, retaining, motivating and rewarding employees who render services that benefit the Company, its subsidiaries and allied business enterprises and aligning the interests of these employees with the Company’s stockholders. An allied business enterprise is a business in which the Company or its subsidiaries have an ownership interest. |
Q: | WHAT CRITERIA MAY THE COMPENSATION COMMITTEE USE TO SPECIFY PERFORMANCE GOALS FOR AWARDS MADE UNDER THE 2024 OMNIBUS PLAN? |
A: | The Compensation Committee may use performance objectives based on one or more measures. Specific performance goals may be based on: |
• | Profits (e.g., operating income; earnings; earnings before interest, taxes, depreciation, and amortization (“EBITDA”); earnings before taxes; net income; earnings per share; residual or economic earnings; economic profit; performance profit (operating income minus an allocated charge approximating the Company’s cost of capital)); |
• | Cash Flow (e.g., free cash flow; free cash flow with or without specific capital expenditure target or range; including or excluding divestments and/or acquisitions; total cash flow; cash flow in excess of cost of capital or residual cash flow or cash flow return on investment); |
74 | | | 2024 Proxy Statement | | |
• | Returns (e.g., profits or cash flow returns on: assets, invested capital, net capital employed, and stockholders’ equity); |
• | Working Capital (e.g., working capital divided by sales; days’ sales outstanding; days’ sales inventory; and days’ sales in payables); |
• | Profit Margins (e.g., Profits divided by revenues; gross margins and material margins divided by revenues; and material margin divided by sales pounds); |
• | Liquidity Measures (e.g., debt-to-capital; debt-to-EBITDA; total debt ratio); |
• | Sales Growth, Gross Margin Growth, Cost Initiative and Stock Price Metrics (e.g., revenues, revenue growth; revenue growth outside the United States; gross margin and gross margin growth; material margin and material margin growth; stock price appreciation; total return to shareholders; sales and administrative costs divided by sales; and sales and administrative costs divided by profits); and |
• | Strategic Initiative Key Deliverable Metrics consisting of one or more of the following: product development; strategic partnering; research and development; vitality index; market penetration; geographic business expansion goals, cost targets; customer satisfaction; employee satisfaction; management of employment practices and employee benefits; supervision of litigation and information technology; and goals relating to acquisitions or divestitures of subsidiaries; affiliates and joint ventures. |
Q: | WHAT IMPACT WILL THE AMENDMENT HAVE ON THE COMPANY’S EQUITY COMPENSATION PLAN RUN RATE? |
A: | Run rate, a means of measuring annual stock dilution, shows how rapidly a company is deploying its shares reserved for issuance under its equity compensation plans. Run rate is calculated as the number of shares of Common Stock subject to awards granted in a given year divided by the number of shares of Common Stock outstanding. As shown in the following table, in the last three fiscal years, the Company’s average annual run rate has been 0.56%. If the stockholders approve and adopt the 2024 Omnibus Plan, the Company estimates its future run rates will be similar to the current rate. |
| Fiscal Year | | | Options/SARs Granted (‘000) | | | Aggregate Full Value Awards Granted (‘000) | | | Weighted Average Basic Common Shares Outstanding (‘000) | | | Annual Run Rate | |
| 2024 | | | 300 | | | 388 | | | 127,767 | | | 0.54% | |
| 2023 | | | 360 | | | 268 | | | 127,507 | | | 0.49% | |
| 2022 | | | 340 | | | 474 | | | 127,948 | | | 0.64% | |
| 3-Year Average Run Rate | | | | | | | | | 0.56% | |
Q: | WHAT IS THE COMPANY’S DILUTION OR OVERHANG AND HOW MANY SHARES ARE AVAILABLE FOR GRANT UNDER ITS CURRENT EQUITY COMPENSATION PLANS? |
A: | Overhang is an analysis of potential dilution to stockholders from the equity being transferred to employees via equity incentive plans. Overhang is calculated by dividing (a) the number of shares of Common Stock issued and options granted but |
| | 2024 Proxy Statement | | | 75 |
| PLAN | | | Outstanding Unexercised Options/SARs | | | Weighted Average Exercise Price | | | Weighted Average Remaining Term | | | Outstanding Full Value Awards | | | Shares Available for Grant | |
| RPM International Inc. 2014 Omnibus Equity and Incentive Plan | | | 2,191,700 | | | $79.11 | | | 6.57 years | | | 997,851 | | | 2,507,583* | |
| RPM International Inc. 1997 Restricted Stock Plan | | | — | | | — | | | — | | | 34,996 | | | — | |
| RPM International Inc. 2007 Restricted Stock Plan | | | — | | | — | | | — | | | 208,847 | | | — | |
| RPM International Inc. 2003 Restricted Stock Plan for Directors | | | — | | | — | | | — | | | 51,400 | | | — | |
| TOTAL | | | 2,191,700 | | | $79.11 | | | 6.57 years | | | 1,293,094 | | | 2,507,583* | |
* | 1,164,365 of the shares available for grant under the 2014 Omnibus Plan may be subject to “full-value” awards. “Full-value” awards are restricted stock, restricted stock unit, performance stock and performance stock unit awards. Of these shares currently available for future grants, the Company commits that it will not make any further awards under the 2014 Omnibus Plan, with the exception of up to 25,000 shares from the 2014 Omnibus Plan for the Directors’ regularly scheduled grants in October 2024 and all other remaining shares will be retired and unavailable for future grants upon the expiration of the 2014 Omnibus Plan. |
Q: | WILL THE COMPANY MAKE ANY FURTHER AWARDS UNDER THE 2014 OMNIBUS PLAN? |
A: | After July 22, 2024 (the date for which shares available for future grant under the 2014 Omnibus Plan are presented in the foregoing table) and through the date of this Proxy Statement, the Company has not made any further awards under the 2014 Omnibus Plan. From the date of this Proxy Statement to the date of the Annual Meeting, the Company commits that it will not make any further awards under the 2014 Omnibus Plan, with the exception of up to 25,000 shares of Common Stock that may be granted on October 3, 2024 immediately preceding the Annual Meeting in the form of restricted stock for non-employee Directors. The amount and timing of these restricted stock awards follows the Company’s annual compensation program for its non-employee Directors. If the Company’s stockholders approve the 2024 Omnibus Plan at the Annual Meeting, no further awards may be made under the 2014 Omnibus Plan as of that date. The 2014 Omnibus Plan will expire by its terms on October 9, 2024. |
Q: | DOES THE 2024 OMNIBUS PLAN PROVIDE FOR THE REPRICING OF OPTIONS? |
A: | The Company has never repriced options or granted options at less than fair market value. The 2024 Omnibus Plan expressly prohibits repricing options or stock appreciation rights, whether directly, by lowering the exercise price of an outstanding option or stock appreciation right, or indirectly, by canceling an outstanding option and granting a replacement option or stock appreciation right at a lower exercise price or another award to replace the option or stock appreciation right. |
Q: | WHAT VOTE IS REQUIRED TO APPROVE AND ADOPT THE 2024 OMNIBUS PLAN? |
A: | The affirmative vote of the holders of a majority of the outstanding Common Stock entitled to vote on the proposal to approve and adopt the 2024 Omnibus Plan and either present in person or by proxy, is required for the approval and adoption of the 2024 Omnibus Plan. Thus, stockholders who vote to abstain will in effect be voting against the proposal. Broker non-votes, however, are not counted as present for determining whether this proposal has been approved and have no effect on its outcome. |
Q: | WHERE CAN I FIND THE TEXT OF THE 2024 OMNIBUS PLAN? |
A: | A copy of the 2024 Omnibus Plan is attached hereto as Appendix B. |
76 | | | 2024 Proxy Statement | | |
Q: | WHO ADMINISTERS THE 2024 OMNIBUS PLAN? |
A: | The 2024 Omnibus Plan is administered by the Compensation Committee. The Board of Directors has discretion and authority to assume the administration of the 2024 Omnibus Plan. Each member of the Compensation Committee is a “non-employee director” within the meaning of Rule 16b-3 promulgated under the Exchange Act. The Compensation Committee’s authority under the 2024 Omnibus Plan includes, but is not limited to, the authority to: (i) select the employees who shall participate in the 2024 Omnibus Plan; (ii) determine the amounts and types of awards; (iii) determine the terms and conditions of awards in a manner consistent with the 2024 Omnibus Plan; (iv) construe and interpret the 2024 Omnibus Plan, all award agreements, and any other agreements or instruments entered into under the plan; (v) establish, amend, or waive rules and regulations for the 2024 Omnibus Plan’s administration; and (vi) amend the terms and conditions of any outstanding award and applicable award agreement to the extent that such terms and conditions are within the discretion of the Compensation Committee, subject to the provisions of the 2024 Omnibus Plan and any applicable law. Further, the Compensation Committee may make all other determinations that may be necessary or advisable for the administration of the 2024 Omnibus Plan. |
Q: | WHO IS ELIGIBLE TO PARTICIPATE IN THE 2024 OMNIBUS PLAN? |
A: | The Compensation Committee, from time to time and in its sole and exclusive discretion, determines those employees of the Company, its subsidiaries and affiliates who are eligible for awards. Approximately 220 employees are currently eligible to receive awards under the 2024 Omnibus Plan and Non-employee Directors are also eligible to receive awards under the 2024 Omnibus Plan. |
Q: | WHAT DOES THE COMPANY RECEIVE FOR GRANTING AWARDS UNDER THE 2024 OMNIBUS PLAN? |
A: | The 2024 Omnibus Plan furthers the growth and financial success of the Company by aligning interests of key employees and Directors more closely with the interests of the Company’s stockholders and to provide employees and Directors with an additional incentive to excel in performing services for the Company and its affiliates. The 2024 Omnibus Plan provides flexibility to the Company and its affiliates in attracting, motivating and retaining key employees and Directors. |
Q: | HOW LONG MAY AWARDS BE MADE UNDER THE 2024 OMNIBUS PLAN? |
A: | Subject to approval by the Company’s stockholders, the 2024 Omnibus Plan will become effective on October 3, 2024. Subject to the Board of Directors’ discretion to terminate the 2024 Omnibus Plan at an earlier date, awards may be granted through October 3, 2034; however, any awards that are outstanding under their terms at the time the 2014 Omnibus Plan is terminated will remain outstanding until fully vested or exercised, or otherwise terminate pursuant to the terms of such awards. |
Q: | WHAT IS THE SOURCE OF THE COMMON STOCK THAT MAY BE AWARDED UNDER THE 2024 OMNIBUS PLAN? |
A: | The Company awards authorized and unissued or treasury shares of Common Stock under the 2024 Omnibus Plan. |
Q: | HOW MANY SHARES OF COMMON STOCK MAY BE ISSUED UNDER THE 2024 OMNIBUS PLAN? |
A: | Up to 5,000,000 shares of Common Stock may be issued with respect to awards under the 2024 Omnibus Plan. |
Q: | HOW MANY SHARES OF COMMON STOCK MAY BE SUBJECT TO “FULL-VALUE” AWARDS? |
A: | No more than 2,500,000 shares of Common Stock may be subject to “full-value” awards under the 2024 Omnibus Plan. “Full-value” awards are restricted stock, restricted stock units, performance shares and unrestricted shares. This limitation relates solely to Common Stock issuable under the 2024 Omnibus Plan. |
Q: | ARE THERE LIMITS ON GRANTS TO INDIVIDUAL PARTICIPANTS? |
A: | Yes. The Board of Directors believes that annual participant limitations on specific types of awards are appropriate. The maximum number of shares of Common Stock subject to option or stock appreciation rights awards that may be granted to any participant (other than non-employee Directors, for whom there is a separate, lower limit of 10,000) during any plan year is |
| | 2024 Proxy Statement | | | 77 |
Q: | ARE SHARES WHICH ARE NO LONGER ISSUABLE PURSUANT TO AWARDS CHARGED AGAINST THE 2024 OMNIBUS PLAN’S SHARE AND AWARD LIMITATIONS? |
A: | No. Shares covered by an award that is forfeited or shares that remain unpurchased or undistributed upon termination or expiration of an award may be used for further awards to the same or other participants. However, the 2024 Omnibus Plan does not add back to the number of shares available under the 2024 Omnibus Plan any shares that are used to pay for the exercise price of an option or stock appreciation right, or any shares used to cover tax withholding obligations. |
Q: | WHAT TYPES OF AWARDS MAY BE GRANTED UNDER THE 2024 OMNIBUS PLAN? |
A: | The 2024 Omnibus Plan provides for several types of cash and stock-based awards. These are stock options and stock appreciation rights, shares of restricted stock, restricted stock units, performance shares, performance units and shares of unrestricted stock. In addition, dividend equivalents may also be awarded with respect to restricted stock units and performance shares. Awards may be linked to other awards (e.g., stock appreciation rights linked to options). Each award is contingent upon a participant’s execution of an award agreement prescribed by the Compensation Committee. |
Q: | ARE THERE MINIMUM VESTING REQUIREMENTS FOR AWARDS GRANTED UNDER THE 2024 OMNIBUS PLAN? |
A: | Generally, any award granted under the 2024 Omnibus Plan must have at least a one-year vesting or performance period. However, 5% of the shares available under the 2024 Omnibus Plan may used for awards with no minimum vesting period. |
Q: | WHAT ARE PERFORMANCE SHARES? |
A: | Performance shares are a right to receive a specified number of shares of Common Stock and/or a cash amount determined by reference to the fair market value of a specified number of shares of Common Stock in the future conditioned upon the attainment of specified performance objectives and such other conditions, restrictions and contingencies as the Compensation Committee may determine. At the time of grant of a performance shares award, the Compensation Committee must specify the performance objectives which, depending on the extent to which they are met, will determine the value of the distribution to the participant. The Compensation Committee will also specify the time period or periods during which the performance objectives must be met (the “Performance Period”). Certain performance criteria that the Compensation Committee may use are provided in the 2024 Omnibus Plan under the definition of “Performance Measures.” (See also, “WHAT CRITERIA MAY THE COMPENSATION COMMITTEE USE TO SPECIFY PERFORMANCE GOALS FOR AWARDS MADE UNDER THE 2024 OMNIBUS PLAN?” above.) |
Q: | WHAT ARE PERFORMANCE UNITS? |
A: | Performance units are rights to receive a specified cash amount (not determined by reference to the fair market value of a specified number of shares of Common Stock) or a number of shares with a fair market value equal to the dollar amount earned if specified performance goals and any other terms and conditions specified in the applicable award agreement are satisfied. |
Q: | WHAT IS THE DIFFERENCE BETWEEN PERFORMANCE SHARES AND PERFORMANCE UNITS? |
A: | The value of performance shares awards is directly related to the value of shares of Common Stock, which will fluctuate over the life of the awards. The value of performance units is established at the time of grant and is not directly related to the value of shares of Common Stock. |
78 | | | 2024 Proxy Statement | | |
Q: | WHAT IS RESTRICTED STOCK? |
A: | Restricted stock is an award of shares of Common Stock that are currently issued to a participant subject to forfeiture, transfer or other restrictions that will cease to apply at a future date or dates when specified conditions provided in the award agreement have been satisfied. Grants of restricted stock may be performance-based or have their restrictions lapse by the passage of time. The Compensation Committee may provide that restrictions lapse upon death, disability or retirement. |
Q: | WHAT ARE RESTRICTED STOCK UNITS? |
A: | Restricted stock units represent a promise to issue shares of Common Stock or pay the cash equivalent to a participant in the future when specified conditions provided in the award agreement have been satisfied. The Compensation Committee may provide that restricted stock unit awards vest upon death, disability or retirement. |
Q: | WHAT IS THE DIFFERENCE BETWEEN RESTRICTED STOCK AND RESTRICTED STOCK UNITS? |
A: | Unlike restricted stock, restricted stock units do not provide the participant-holder with the rights of a stockholder prior to lapse of the restrictions. Thus, recipients of restricted stock awards have stockholder rights while recipients of restricted stock unit awards do not. However, if a grant of restricted stock is prospective-performance-based, any dividends issued with respect to the shares will be deferred and paid contingently upon the achievement of the underlying performance goals. |
Q: | WHAT ARE DIVIDEND EQUIVALENTS? |
A: | Dividend equivalents are rights to be paid an amount equal to the dividends paid on a specified number of shares of Common Stock. Dividend equivalents are based on the number of shares of Common Stock subject to an award (other than stock options or stock appreciation rights) under the 2024 Omnibus Plan. For any awards that are performance-based, any dividend equivalents associated with the award will be deferred and paid contingently upon achievement of the award’s underlying performance goals. Dividend equivalents may not be awarded with respect to stock options or stock appreciation rights. |
Q: | WHAT TYPES OF STOCK OPTIONS MAY BE AWARDED? |
A: | Incentive stock options (“ISOs”) and nonqualified stock options (“NQSOs”). ISOs are intended to meet the requirements for favorable tax treatment under Section 422 of the Code. NQSOs are stock options that do not meet those requirements. |
Q: | DO ANY SPECIAL RESTRICTIONS APPLY TO INCENTIVE STOCK OPTIONS? |
A: | Yes. An ISO may only be granted to employees (including officers and Directors who are also employees) of the Company or a “subsidiary corporation” as defined in the Code. No ISO may be exercisable on or after the 10th anniversary of the date of grant, nor may any ISO be granted on or after the tenth anniversary of the effective date of the 2024 Omnibus Plan (such anniversary will be October 3, 2034, if the 2024 Omnibus Plan is approved by the Company’s stockholders at the Annual Meeting). The exercise price of an ISO cannot be less than the fair market value of the underlying stock on the date of grant, which generally means the last closing price of the stock as reported on the NYSE on the date of grant. If an ISO is granted to a participant who owns, at the time of grant, in excess of 10% of the total outstanding shares of Common Stock of the Company, the exercise price of the ISO must be at least 110% of the fair market value of the underlying stock on the date of grant and the term of the ISO cannot be longer than five years from the date of grant. The total fair market value of shares subject to ISOs which are exercisable for the first time by any participant in any given calendar year (under any plan of the Company and related companies) cannot exceed $100,000 (valued as of the date of grant). No ISO may be exercisable more than three months following termination of employment for any reason other than death or disability, nor more than one year with respect to disability terminations, or such option will no longer qualify as an ISO and will therefore be treated as an NQSO. ISOs are also non-transferable in accordance with the provisions of the Code. |
Q: | HOW IS THE EXERCISE PRICE OF STOCK OPTIONS DETERMINED? |
A: | For ISOs and NQSOs, the exercise price will not be less than the fair market value of a share of Common Stock on the date the option is granted multiplied by the number of shares subject to the option. The exercise price of ISOs granted to individuals with at least a 10% voting interest in the Company or related companies will be 110% of such exercise price. As of August 9, 2024, the fair market value of a share of the Company’s Common Stock was $114.40. |
| | 2024 Proxy Statement | | | 79 |
Q: | WHEN ARE STOCK OPTIONS EXERCISABLE? |
A: | Stock options are exercisable at such time or times provided in the applicable award agreement but, in any event, before their expiration or termination. A performance-based stock option may provide that it will become exercisable, if at all, only upon achievement of one or more performance goals. The Compensation Committee may provide that a stock option becomes exercisable upon death, disability or retirement. |
Q: | WHEN DOES AN OPTION TERMINATE? |
A: | The 2024 Omnibus Plan provides that options shall not have a term of more than ten years (five years for ISOs granted to individuals with at least a 10% voting interest in the Company or related companies). The Compensation Committee may impose a shorter term under the applicable award agreement. |
Q: | WHAT IS A STOCK APPRECIATION RIGHT? |
A: | A Stock Appreciation Right (“SAR”) may be free-standing or supplemental to a stock option. Upon exercise, the holder of a SAR is entitled to the amount by which the fair market value of a share of Common Stock on the date of exercise exceeds the exercise price multiplied by the number of SARs exercised. The exercise price of a SAR is the fair market value of a share of common stock on the date of grant unless the Compensation Committee specified a higher exercise price when the SARs were granted. If a supplemental SAR is granted, the holder of the SAR is entitled to an amount under the SAR in addition to the proceeds of the stock option provided that the holder purchases shares under the stock option. |
Q: | WHEN DO SARs TERMINATE? |
A: | The 2024 Omnibus Plan provides that the Compensation Committee will impose an expiration date under the applicable SAR award agreement. Freestanding SARs have a maximum term of ten years, and Affiliated SARs and Tandem SARs are subject to the maximum ten-year term of the associated option. |
Q: | WHAT FORM OF PAYMENT IS REQUIRED WHEN A STOCK APPRECIATION RIGHT IS EXERCISED? |
A: | Upon exercise, interests in SARs may be distributed in cash, shares of Common Stock or a combination of the two, as the Compensation Committee may determine. |
Q: | DO PARTICIPANTS HAVE STOCKHOLDER RIGHTS? |
A: | Recipients of restricted stock will ordinarily have stockholder rights, including dividend and voting rights, except, with respect to performance-based restricted stock, any dividends for such shares will be deferred and paid contingently upon the achievement of the underlying performance measures. Recipients of restricted stock unit awards, performance shares, performance unit awards, SARs and options ordinarily will not have stockholder rights unless and until shares of Common Stock are distributed to the recipient pursuant to those awards. |
Q: | MAY PARTICIPANTS TRANSFER THEIR 2024 OMNIBUS PLAN INTERESTS? |
A: | Generally, no. All awards are non-transferable and may be exercised only by the grantee and may not be transferred other than by will, by the laws of descent and distribution or by beneficiary designation. Non-transferable awards are exercisable during a participant’s lifetime only by the participant or, as permitted by applicable law, the participant’s guardian or other legal representative. Other than pursuant to a permitted transfer, no award may be assigned, pledged, hypothecated or otherwise alienated or encumbered (whether by operation of law or otherwise) and any attempts to do so will be null and void. |
Q: | WHAT HAPPENS TO AWARDS UPON TERMINATION OF EMPLOYMENT? |
A: | Generally, awards are forfeited upon a participant’s termination of employment. However, the Compensation Committee has discretion to provide otherwise that: (1) awards become non-forfeitable, fully-earned and payable; and (2) stock options and SARs become exercisable, on the date of termination of employment or as a result of a specific event of termination of employment such as retirement, death or disability. |
80 | | | 2024 Proxy Statement | | |
Q: | WHAT HAPPENS IF THERE IS A CHANGE IN THE COMPANY’S CAPITAL STRUCTURE? |
A: | The 2024 Omnibus Plan provides that in the event of any change in the shares of Common Stock by virtue of a stock dividend, stock split or consolidation, reorganization, merger, spinoff, extraordinary dividend, or similar transaction, the Compensation Committee will, as it deems appropriate, adjust (i) the aggregate number and kind of shares available for awards, (ii) the number and kind of shares subject to an award, (iii) the number of shares available for certain awards under the individual and plan limits set forth in the plan and (iv) the terms of the award, including its exercise price, to prevent the dilution of shares or the diminution of the awards. Moreover, in the event of any such transaction or event or in the event of a change in control of the Company, the Compensation Committee may provide in substitution for any or all outstanding awards under the 2024 Omnibus Plan such alternative consideration (including cash) that it may determine to be equitable in the circumstances and may require the surrender of the replaced awards in a manner that complies with Section 409A of the Code. In addition, for each stock option or stock appreciation right with an exercise price greater than the consideration offered in connection with any change in control event, the Compensation Committee may elect to cancel such stock option or stock appreciation right without any payment to the award’s holder. |
Q: | WHAT HAPPENS IF THERE IS A CHANGE IN CONTROL OF THE COMPANY? |
A: | The treatment of outstanding awards upon a change in control would depend on whether or not the Company remains the surviving entity following the change in control. In general, a change in control will be deemed to have occurred under the 2024 Omnibus Plan if: (i) the Company consummates a reorganization, merger or consolidation resulting in a substantial change in ownership of 50% or more of the voting power of the Company; (ii) the Company consummates a sale of all or substantially all of its assets; (iii) a person or group acquires 25% or more of the voting power of the Company in the election of Directors (excluding certain purchases by the Company, its affiliates or its benefit plans); or (iv) the Company experiences a turn-over (not approved by at least two-thirds of the Company’s Directors) of a majority of its Directors during a two-year period. |
| | 2024 Proxy Statement | | | 81 |
Q: | WHAT ARE THE U.S. FEDERAL INCOME TAX CONSEQUENCES OF AWARDS FOR THE COMPANY AND PARTICIPANTS? |
A: | The Company has been advised that under current law certain of the income tax consequences under the laws of the United States to participants and the Company should generally be as set forth in the following summary. This summary only addresses income tax consequences for participants and the Company. |
82 | | | 2024 Proxy Statement | | |
| | 2024 Proxy Statement | | | 83 |
| Your Board recommends a vote “FOR” Proposal Five. | |
| | |
| |
84 | | | 2024 Proxy Statement | | |
| | | May 31, | | ||||
| | | 2024 | | | 2023 | | |
| Audit Fees | | | $7,656,176 | | | $7,095,366 | |
| Audit-Related Fees | | | 13,700 | | | 71,095 | |
| Tax Services | | | 887,067 | | | 912,167 | |
| All Other Fees | | | — | | | — | |
| Total Fees | | | $8,556,943 | | | $8,078,628 | |
| | 2024 Proxy Statement | | | 85 |
86 | | | 2024 Proxy Statement | | |
| Name of Beneficial Owner | | | Number of Shares of Common Stock Beneficially Owned(1) | | | Percentage of Shares of Common Stock(1) | |
| The Vanguard Group(2) | | | 14,220,983 | | | 11.0 | |
| BlackRock, Inc.(3) | | | 13,219,426 | | | 10.3 | |
| Aristotle Capital Management, LLC(4) | | | 9,578,480 | | | 7.4 | |
| Kirkland B. Andrews(5) | | | 11,628 | | | * | |
| John M. Ballbach(6) | | | 19,474 | | | * | |
| Bruce A. Carbonari(7) | | | 42,521 | | | * | |
| Jenniffer D. Deckard(8) | | | 14,845 | | | * | |
| Salvatore D. Fazzolari(9) | | | 19,549 | | | * | |
| Russell L. Gordon(10) | | | 205,566 | | | 0.2 | |
| Janeen B. Kastner(11) | | | 187,706 | | | 0.1 | |
| Timothy R. Kinser(12) | | | 24,090 | | | * | |
| Robert A. Livingston(13) | | | 16,159 | | | * | |
| Edward W. Moore(14) | | | 58,718 | | | * | |
| Frederick R. Nance(15) | | | 8,180 | | | * | |
| Ellen M. Pawlikowski(16) | | | 3,700 | | | * | |
| Frank C. Sullivan(17) | | | 1,361,998 | | | 1.1 | |
| William B. Summers, Jr.(18) | | | 46,188 | | | * | |
| Elizabeth F. Whited(19) | | | 4,300 | | | * | |
| All Directors and executive officers as a group (seventeen persons including the Directors, Director nominees and executive officers named above)(20) | | | 2,060,022 | | | 1.6 | |
* | Less than 0.1%. |
(1) | In accordance with Securities and Exchange Commission (“Commission”) rules, each beneficial owner’s holdings have been calculated assuming full exercise of outstanding stock-settled appreciation rights covering Common Stock, if any, exercisable by such owner within 60 days after May 31, 2024, but no exercise of outstanding stock-settled appreciation rights covering Common Stock held by any other person. |
(2) | According to an amended Schedule 13G filed with the Commission on February 13, 2024, The Vanguard Group (“Vanguard”), as of December 29, 2023, has shared voting power over 70,496 shares of Common Stock, sole dispositive power over 14,044,091 shares of Common Stock, and shared dispositive power over 176,892 shares of Common Stock shown in the table above. Vanguard is located at 100 Vanguard Blvd., Malvern, Pennsylvania 19355. |
(3) | According to an amended Schedule 13G filed with the Commission on March 7, 2024, BlackRock, Inc., together with its subsidiaries BlackRock Life Limited, BlackRock International Limited, BlackRock Advisors, LLC, Aperio Group, LLC, BlackRock (Netherlands) B.V., BlackRock Institutional Trust Company, National Association, BlackRock Asset Management Ireland Limited, BlackRock Financial Management, Inc., BlackRock Japan Co., Ltd., BlackRock Asset Management Schweiz AG, BlackRock Investment Management, LLC, BlackRock Investment Management (UK) Ltd., BlackRock Asset Management Canada Limited, |
| | 2024 Proxy Statement | | | 87 |
(4) | According to an amended Schedule 13G filed with the Commission on February 14, 2024, Aristotle Capital Management, LLC (“Aristotle”), as of December 31, 2023, has sole voting power over 8,832,243 shares of Common Stock, and sole dispositive power over the 9,578,480 shares of Common Stock shown in the table above. Aristotle is located at 11100 Santa Monica Blvd., Suite 1700, Los Angeles, California 90025. |
(5) | Mr. Andrews is a Director of the Company. |
(6) | Mr. Ballbach is a Director of the Company. |
(7) | Mr. Carbonari is a Director of the Company. |
(8) | Ms. Deckard is a Director of the Company. |
(9) | Mr. Fazzolari is a Director of the Company. |
(10) | Mr. Gordon is an executive officer of the Company. His ownership is comprised of 120,749 shares of Common Stock which he owns directly and 84,817 shares of Common Stock issuable under stock-settled stock appreciation rights currently exercisable or exercisable within 60 days of May 31, 2024. |
(11) | Ms. Kastner is an executive officer of the Company. Her ownership is comprised of 119,190 shares of Common Stock which she owns directly, 67,433 shares of Common Stock issuable under stock-settled stock appreciation rights currently exercisable or exercisable within 60 days of May 31, 2024, and approximately 1,083 shares of Common Stock held by Fidelity Management Trust Company, as trustee of the RPM International Inc. 401(k) Plan, which represents Ms. Kastner’s approximate percentage ownership of the total shares of Common Stock held in the RPM International Inc. 401(k) Plan as of May 31, 2024. |
(12) | Mr. Kinser is an executive officer of the Company. His ownership is comprised of 20,454 shares of Common Stock which he owns directly and 3,636 shares of Common Stock issuable under stock-settled stock appreciation rights currently exercisable or exercisable within 60 days of May 31, 2024. |
(13) | Mr. Livingston is a Director of the Company. |
(14) | Mr. Moore is an executive officer of the Company. His ownership is comprised of 56,209 shares of Common Stock which he owns directly and 4,871 shares of Common Stock issuable under stock-settled stock appreciation rights currently exercisable or exercisable within 60 days of May 31, 2024. |
(15) | Mr. Nance is a Director of the Company. |
(16) | Gen. Pawlikowski is a Director of the Company. |
(17) | Mr. Sullivan is a Director and an executive officer of the Company. Mr. Sullivan’s ownership is comprised of 1,025,072 shares of Common Stock which he owns directly, 3,000 shares of Common Stock which he holds as custodian for his son, 313,265 shares of Common Stock issuable under stock-settled stock appreciation rights currently exercisable or exercisable within 60 days of May 31, 2024, 15,600 shares of Common Stock held in a trust for the benefit of Mr. Sullivan, and approximately 5,061 shares of Common Stock held by Fidelity Management Trust Company, as trustee of the RPM International Inc. 401(k) Plan, which represents Mr. Sullivan’s approximate percentage ownership of the total shares of Common Stock held in the RPM International Inc. 401(k) Plan as of May 31, 2024. Ownership of the shares of Common Stock held as custodian for his son and those held in a trust for the benefit of his son is attributed to Mr. Sullivan pursuant to Commission rules. |
(18) | Mr. Summers is a Director of the Company. |
(19) | Ms. Whited is a Director of the Company. |
(20) | The number of shares of Common Stock shown as beneficially owned by the Directors, Director nominees and executive officers as a group on May 31, 2024 includes approximately 6,144 shares of Common Stock held by Fidelity Management Trust Company, as trustee of the RPM International Inc. 401(k) Plan, which represents the group’s approximate percentage ownership of the total shares of Common Stock held in the RPM International Inc. 401(k) Plan as of May 31, 2024. |
88 | | | 2024 Proxy Statement | | |
| | 2024 Proxy Statement | | | 89 |
90 | | | 2024 Proxy Statement | | |
| | 2024 Proxy Statement | | | A-1 |
(a) | “2014 Plan” means the RPM International Inc. Amended and Restated 2014 Omnibus Equity and Incentive Plan. |
(b) | “Act” or “1934 Act” means the Securities Exchange Act of 1934, as amended from time to time. |
(c) | “Affiliate” means any corporation or any other entity (including, but not limited to, a partnership, limited liability company, joint venture, or Subsidiary) controlling, controlled by, or under common control with the Company. |
(d) | “Affiliated SAR” means an SAR that is granted in connection with a related Option and is deemed to be exercised at the same time as the related Option is exercised. |
(e) | “Aggregate Share Limit” has the meaning specified in Section 4.01(a). |
(f) | “Award” means, individually or collectively, a grant under the Plan of Nonqualified Stock Options, Incentive Stock Options, Stock Appreciation Rights, shares of Restricted Stock, Restricted Stock Units, Performance Units, Performance Shares or unrestricted Shares. |
(g) | “Award Agreement” means the written agreement that sets forth the terms and conditions applicable to an Award. |
(h) | “Board” or “Board of Directors” means the Company’s Board of Directors, as constituted from time to time. |
(i) | “Cashless Exercise” means, if there is a public market for the Shares, the payment of the Exercise Price for Options through a same day sale commitment from the Participant and a FINRA member firm, whereby the Participant irrevocably elects to exercise the Option and to sell a portion of the Shares so purchased to pay the Exercise Price, and whereby the FINRA member firm irrevocably commits upon receipt of such stock to forward the Exercise Price directly to the Company. |
| | 2024 Proxy Statement | | | B-1 |
(j) | “Cause” means the occurrence of any of the following events that occurs within the two-year period following a Change in Control: (i) Participant’s commission of a felony or any crime of moral turpitude; (ii) Participant’s willful conduct that is reasonably likely to materially impair the reputation of the Company or its Affiliates; (iii) Participant’s fraud, misappropriation or embezzlement of any business opportunity, funds or property of the Company or its Affiliates (whether attempted or actual); (iv) Participant’s breach of an agreement with the Company or one of its Affiliates, failure to adhere to a written rule or policy of the Company or one of its Affiliates, or failure to carry out, or comply with, in any material respect, any clear and reasonably attainable directive made in good faith; provided, however, that if such breach or failure described in clause (iv) is reasonably susceptible to cure, the Company or its Affiliate shall notify Participant in writing of the acts believed to constitute such breach or failure, and if Participant corrects or remedies such acts within fifteen (15) business days after such notice is given, then such breach or failure shall not be deemed to be “Cause” hereunder; or (v) Participant’s voluntary resignation or other termination of employment or service effected by Participant under circumstances in which the Company could effect such termination with Cause pursuant to this Plan. |
(k) | “Change in Control” has the meaning specified in Section 14.01. |
(l) | “Code” means the Internal Revenue Code of 1986, as amended from time to time. |
(m) | “Committee” means the Compensation Committee of the Board or such other committee appointed by the Board that complies with Section 3.01 to administer the Plan. |
(n) | “Company” means RPM International Inc., a Delaware corporation, and any successor thereto. |
(o) | “Director” means any individual who is a member of the Board of Directors. |
(p) | “Effective Date” means October 3, 2024, which is the date on which the Company’s stockholders initially approved the Plan. |
(q) | “Employee” means an officer or key employee of the Company or an Affiliate, a leased employee or an individual who provides services for the Company or any Affiliate that is substantially similar to services an employee would provide. |
(r) | “Exercise Price” means, (i) with respect to an Option, the price at which a Share may be purchased by a Participant pursuant to the exercise of such Option; and (ii) with respect to a SAR, the base amount of such SAR. |
(s) | “Fair Market Value” means, with respect to a Share as of a particular date, the per share closing price for the Shares on such date, as reported by the principal exchange or market over which the Shares are then listed or regularly traded. If the Shares are not traded over the applicable exchange or market on the date as of which the determination of Fair Market Value is made, “Fair Market Value” means the per share closing price for the Shares on the most recent preceding date on which the Shares were traded over such exchange or market. If the Shares are not traded on any national securities exchange or market, the “Fair Market Value” of a Share shall be determined by the Committee in a reasonable manner pursuant to a reasonable valuation method. Notwithstanding anything to the contrary in the foregoing, as of any date, the “Fair Market Value” of a Share shall be determined in a manner consistent with avoiding adverse tax consequences under Code Section 409A and, with respect to an Incentive Stock Option, in the manner required by Code Section 422. |
(t) | “FINRA” means the Financial Industry Regulatory Authority. |
(u) | “Fiscal Year” means the annual accounting period of the Company. |
(v) | “Freestanding SAR” means an SAR that is granted independently of any Option. |
(w) | “Grant Date” means the date specified by the Committee or the Board, or a delegate of the Committee or the Board, on which a grant of an Award under this Plan will become effective, which date will not be earlier than the date on which the Committee or the Board, or a delegate of the Committee or the Board, takes action with respect thereto. |
B-2 | | | 2024 Proxy Statement | | |
(x) | “Good Reason” means the occurrence of one or more of the following events within the two- year period following a Change in Control: |
(i) | a significant reduction in the nature or scope of the title, authority or responsibilities of the Participant from those held by the Participant immediately prior to the Change in Control or a relocation of the Participant’s primary place of employment to a new location that is greater than twenty-five (25) miles from the location immediately prior to the Change in Control; |
(ii) | a reduction in the Participant’s (a) annual base salary from the amount in effect on the date of the Change in Control, or (b) annual cash incentive compensation from the amount of the Participant’s annual cash incentive compensation earned for the fiscal year preceding the fiscal year in which the Participant’s termination of employment occurs, unless such reduction results solely from the Company’s results of operations; |
(iii) | the failure by the Company to offer to the Participant an economic value of benefits reasonably comparable to the economic value of benefits under the benefit plans in which the Participant participates at the time of the Change in Control; |
(iv) | the failure by the Company to comply with and satisfy Section 15.08 of this Plan, relating to the assumption of this Plan and the Company’s obligations hereunder by any successor entity, or any other action or inaction that constitutes a material breach by the Company of this Plan, any Award Agreement or any other agreement under which the Participant provides his or her services to the Company; or |
(v) | the Company materially changes its strategic direction, which shall be deemed to occur in the event of (a) any material change in the Company’s group operating structure from that in place immediately prior to the Change in Control; (b) any sale, liquidation, or other disposition or discontinuation of any business or businesses that represent, individually or in the aggregate, greater than 20% of the Company’s revenue, income from operations or cash flow during the most recent fiscal year completed prior to the Change in Control; or (c) any material change in the principal methods of sourcing raw materials for, manufacturing of, or methods of distribution with respect to, products that represent, individually or in the aggregate, greater than 20% of the Company’s revenue, income from operations or cash flow during the most recent fiscal year completed prior to the Change in Control. |
(y) | “Incentive Stock Option” means an option to purchase Shares that is granted pursuant to the Plan, is designated as an “incentive stock option,” and satisfies the requirements of Code Section 422. |
(z) | “Nonemployee Director” means a Director who is not an Employee. |
(aa) | “Nonqualified Stock Option” means an option to purchase Shares that is granted pursuant to the Plan and is not an Incentive Stock Option. |
(bb) | “Option” means an Incentive Stock Option or a Nonqualified Stock Option. |
(cc) | “Option Period” means the period during which an Option is exercisable in accordance with the applicable Award Agreement and Article VI. |
(dd) | “Participant” means an Employee to whom an Award has been granted. |
(ee) | “Performance Award” means an Award under which the amount payable to a Participant (if any) is contingent on the achievement of pre-established Performance Targets during the Performance Period. |
| | 2024 Proxy Statement | | | B-3 |
(ff) | “Performance Measures” means, with respect to a Performance Award, the objective factors used to determine the amount (if any) payable pursuant to the Award. “Performance Measures” shall be based on any of the factors listed below, alone or in combination, as determined by the Committee. Such factors may be applied (i) on a corporate-wide or business-unit basis, (ii) including or excluding one or more Affiliates or Subsidiaries, (iii) in comparison with plan, budget, or prior performance, and/or (iv) on an absolute basis or in comparison with peer-group performance. The factors that may be used as Performance Measures are: |
(i) | Profits (e.g., operating income; earnings; earnings before interest, taxes, depreciation, and amortization (“EBITDA”); earnings before taxes; net income; earnings per share; residual or economic earnings; economic profit; performance profit (operating income minus an allocated charge approximating the Company’s cost of capital)); |
(ii) | Cash Flow (e.g., free cash flow; free cash flow with or without specific capital expenditure target or range; including or excluding divestments and/or acquisitions; total cash flow; cash flow in excess of cost of capital or residual cash flow or cash flow return on investment); |
(iii) | Returns (e.g., profits or cash flow returns on: assets, invested capital, net capital employed, and stockholders’ equity); |
(iv) | Working Capital (e.g., working capital divided by sales; days’ sales outstanding; days’ sales inventory; and days’ sales in payables); |
(v) | Profit Margins (e.g., Profits divided by revenues; gross margins and material margins divided by revenues; and material margin divided by sales pounds); |
(vi) | Liquidity Measures (e.g., debt-to-capital; debt-to-EBITDA; total debt ratio); |
(vii) | Sales Growth, Gross Margin Growth, Cost Initiative and Stock Price Metrics (e.g., revenues, revenue growth; revenue growth outside the United States; gross margin and gross margin growth; material margin and material margin growth; stock price appreciation; total return to stockholders; sales and administrative costs divided by sales; and sales and administrative costs divided by profits); and |
(viii) | Strategic Initiative Key Deliverable Metrics consisting of one or more of the following: product development; strategic partnering; research and development; vitality index; market penetration; geographic business expansion goals, cost targets; customer satisfaction; employee satisfaction; management of employment practices and employee benefits; supervision of litigation and information technology; and goals relating to acquisitions or divestitures of subsidiaries; affiliates and joint ventures. |
(gg) | “Performance Period” means the period of time during which Performance Targets must be achieved with respect to an Award, as established by the Committee. |
(hh) | “Performance Share” means an Award granted to a Participant pursuant to Section 10.01, the initial value of which is equal to the Fair Market Value of a Share on the Grant Date. |
(ii) | “Performance Targets” means, with respect to a Performance Award for a Performance Period, the objective performance under the Performance Measures for that Performance Period that will result in payments under the Performance Award. Performance Targets may differ from Participant to Participant and Award to Award. |
B-4 | | | 2024 Proxy Statement | | |
(jj) | “Performance Unit” means an Award granted to a Participant pursuant to Section 10.01, the initial value of which is established by the Committee on or before the Grant Date. |
(kk) | “Period of Restriction” means the period during which a Share of Restricted Stock is subject to restrictions and a substantial risk of forfeiture. |
(ll) | “Plan” means the RPM International Inc. 2024 Omnibus Equity and Incentive Plan, as set out in this instrument and as amended from time to time. |
(mm) | “Restricted Stock” means an Award granted to a Participant pursuant to Section 8.01. |
(nn) | “Restricted Stock Unit” means an Award granted to a Participant pursuant to Section 9.01 and represents the right of the Participant to receive Shares or cash at the end of the specified period. |
(oo) | “Rule 16b-3” means Rule 16b-3 under the 1934 Act and any future rule or regulation amending, supplementing, or superseding such rule. |
(pp) | “Section 16 Person” means a person subject to potential liability under Section 16(b) of the 1934 Act with respect to transactions that involve equity securities of the Company. |
(qq) | “Shares” means the whole shares of issued and outstanding regular voting shares of common stock, par value $0.01 per share, of the Company, whether presently or hereafter issued and outstanding, and any other stock or securities resulting from adjustment thereof as provided in 4.04, or the stock of any successor to the Company that is so designated for the purposes of the Plan. |
(rr) | “Spread” means (i) with respect to a free-standing SAR, the excess of the Fair Market Value per Share on the date when a SAR is exercised over the Exercise Price provided for in the related Award Agreement; or (ii) with respect to a tandem SAR, the excess of the Fair Market Value per Share on the date when the related portion of the Option is surrendered over the Exercise Price provided for in the Award Agreement for the related Option. |
(ss) | “Stock Appreciation Right” or “SAR” means an Award, granted alone or in connection or tandem with a related Option, that is designated as an SAR pursuant to Section 7.01, which shall generally be a right of the Participant to receive from the Company an amount determined by the Committee that is expressed as a percentage of the Spread (not exceeding 100 percent) at the time of exercise of the SAR. |
(tt) | “Subsidiary” means any corporation in an unbroken chain of corporations beginning with the Company, if each of the corporations other than the last corporation in the unbroken chain then owns stock or other equity interests possessing fifty percent (50%) or more of the total combined voting power of all classes of stock (in the election of directors or similar governing body) in one of the other corporations in the chain. |
(uu) | “Tandem SAR” means an SAR that is granted in tandem with a related Option, the exercise of which requires forfeiture of the right to exercise the related Option with respect to an equal number of Shares and that is forfeited to the extent that the related Option is exercised. |
| | 2024 Proxy Statement | | | B-5 |
(vv) | “Termination of Service,” “Terminates Service,” or any variation thereof means a separation from service within the meaning of Treasury Regulation 1.409A-1(h). |
(a) | Except to the extent preempted by United States federal law or as otherwise expressly provided herein, the Plan and all Award Agreements shall be interpreted in accordance with and governed by the internal laws of the State of Delaware without giving effect to any choice or conflict of law provisions, principles, or rules. |
(b) | The Plan and all Awards are intended to be exempt from or comply with the requirements of Code Section 409A and all other applicable laws, and this Plan shall be so interpreted and administered. In addition to the general amendment rights of the Company with respect to the Plan, the Company specifically retains the unilateral right (but not the obligation) to make, prospectively or retroactively, any amendment to this Plan and any Award Agreement or any related document as it deems necessary or desirable to more fully address issues in connection with compliance with (or exemption from) Code Section 409A. In no event, however, shall this section or any other provisions of this Plan be construed to require the Company to provide any gross-up for the tax consequences of any provisions of, or payments under, this Plan. Except as may be expressly provided in another agreement to which the Company is bound, the Company and its Affiliates shall have no responsibility for tax or legal consequences to any Participant (or beneficiary) resulting from the terms or operation of this Plan. |
(c) | Any reference herein to a provision of law, regulation, or rule shall be deemed to include a reference to the successor of such law, regulation, or rule. |
(d) | To the extent consistent with the context, any masculine term shall include the feminine, and vice versa, and the singular shall include the plural, and vice versa. |
(e) | If any provision of the Plan shall be held illegal or invalid for any reason, the illegality or invalidity of that provision shall not affect the remaining parts of the Plan, and the Plan shall be interpreted and enforced as if the illegal or invalid provision had never been included herein. |
(f) | The grant of Awards and issuance of Shares hereunder shall be subject to all applicable statutes, laws, rules, and regulations and to such approvals and requirements as may be required from time to time by any governmental authority or securities exchange or market on which the Shares are then listed or traded. |
(g) | The descriptive headings and sections of the Plan are provided for convenience of reference only and shall not serve as a basis for interpretation of the Plan. |
B-6 | | | 2024 Proxy Statement | | |
(a) | Subject to adjustment as provided in Section 4.06 and any limitations specified elsewhere in the Plan: |
(i) | the maximum aggregate number of Shares which may be issued under this Plan pursuant to Awards is five million (5,000,000) Shares (the “Aggregate Share Limit”); |
(ii) | not more than two million, five hundred thousand (2,500,000) Shares may be issued under this Plan pursuant to grants of Restricted Stock, Restricted Stock Units, Performance Units, Performance Shares and unrestricted Shares; and |
(iii) | notwithstanding the foregoing, any Shares covered by an award under this Plan that are forfeited or remain unpurchased or undistributed upon termination or expiration of the award may be reissued under this Plan. |
(b) | Shares covered by an Award granted under the Plan shall not be counted as used unless and until they are actually issued and delivered to a Participant and, therefore, the Aggregate Share Limit as of a given date shall not be reduced by any Shares relating to prior awards that have expired or have been forfeited or cancelled. If the Company pays the benefit provided by any Award granted under the Plan to the respective Participant in cash, any Shares that were covered by such Award will be available for issue or transfer hereunder. Notwithstanding anything to the contrary contained herein: |
(i) | if Shares are tendered or otherwise used in payment of the Exercise Price of an Option, the total number of Shares covered by the Option being exercised shall count against the Aggregate Share Limit; |
(ii) | any Shares used in payment or withheld by the Company to satisfy a tax withholding obligation shall count against the Aggregate Share Limit; |
(iii) | the number of Shares covered by a SAR, to the extent that it is exercised and settled in Shares, and whether or not Shares are actually issued to the Participant upon exercise of the SAR, shall be considered issued or transferred pursuant to the Plan and shall count against the Aggregate Share Limit; and |
(iv) | in the event that the Company repurchases Shares with proceeds from the exercise of an Option, those Shares will not be added to the Aggregate Share Limit. |
(c) | If, under the Plan, a Participant has elected to give up the right to receive compensation in exchange for Shares based on their Fair Market Value, such Shares will not count against the Aggregate Share Limit. |
| | 2024 Proxy Statement | | | B-7 |
(d) | Shares issued under the Plan may be authorized but unissued Shares, treasury Shares, reacquired Shares (including Shares purchased in the open market), or any combination thereof, as the Committee may from time to time determine. Shares covered by an Award that are forfeited or that remain unpurchased or undistributed upon termination or expiration of the Award may be made the subject of further Awards to the same or other Participants. |
(e) | Subject to adjustment pursuant to Section 4.06 hereof, the total number of Shares actually issued or transferred by the Company upon the exercise of Incentive Stock Options will not exceed 5,000,000 Shares. |
(f) | The number of shares issued with respect to Restricted Stock, Restricted Stock Units, Performance Shares and Performance Units or unrestricted Shares (after taking into account any forfeitures and cancellations) will not exceed an aggregate of 2,500,000 Shares during the life of the Plan (or until the Company’s stockholders approve additional Shares to be issued under the Plan). |
(a) | no Employee will be granted Options or SARs for more than 500,000 Shares, in the aggregate, during any calendar year; and |
(b) | no Employee will be granted Awards of Restricted Stock, Restricted Stock Units or Performance Shares for more than 500,000 Shares, in the aggregate, during any calendar year. |
(c) | no Nonemployee Director will be granted Options, SARs, or Awards of Restricted Stock, Restricted Stock Units or Performance Shares for more than 10,000 Shares, in the aggregate, during any calendar year. |
B-8 | | | 2024 Proxy Statement | | |
| | 2024 Proxy Statement | | | B-9 |
(a) | Nonqualified Stock Options. The per-Share Exercise Price under a Nonqualified Stock Option shall be not less than one hundred percent (100%) of Fair Market Value of a Share on the Grant Date. |
(b) | Incentive Stock Options. The per-Share Exercise Price under an Incentive Stock Option shall be not less than one hundred percent (100%) of Fair Market Value of a Share on the Grant Date; provided, however, if, on the Grant Date, the Participant (together with persons whose stock ownership is attributed to the Participant pursuant to Code Section 424(d)) owns securities possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or any of its Subsidiaries, the per-Share Exercise Price shall be not less than one hundred ten percent (110%) of the Fair Market Value of a Share on the Grant Date. |
(c) | Substitute Options. Notwithstanding the provisions of Subsections (a) and (b), if the Company or an Affiliate consummates a transaction described in Code Section 424(a) (e.g., the acquisition of property or stock from an unrelated corporation), individuals who become Employees or Directors on account of such transaction may be granted Options in substitution for options granted by such former employer or recipient of services. If such substitute Options are granted, the Committee, in its sole discretion and consistent with Code Section 424(a) and the requirements of Code Section 409A, may determine that such substitute Options shall have an Exercise Price less than one hundred (100%) of the Fair Market Value of the Shares to which the Options relate determined as of the Grant Dates. In carrying out the provisions of this Section, the Committee shall apply the principles contained in Section 4.06. |
(a) | Options shall not be exercisable more than ten years after their respective Grant Dates; |
(b) | Incentive Stock Options granted to an Employee who possesses more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or any Subsidiary, taking into account the attribution rules of Code Section 422(d), shall not be exercisable later than five years after their respective Grant Date(s); and |
(c) | Subject to the limits of this Article, the Committee may, in its sole discretion, after an Option is granted, extend the option term, provided that such extension is not an extension for purposes of Code Section 409A and the guidance thereunder or, in the case of an Incentive Stock Option, a modification, extension, or renewal for purposes of Code Section 424(h). |
(a) | subject to any conditions or limitations established by the Committee, delivering Shares already owned by the Participant and having a total Fair Market Value on the date of such delivery equal to the portion of the Exercise Price paid; |
(b) | to the extent permitted by law, the delivery of cash by a broker-dealer pursuant to a Cashless Exercise; |
B-10 | | | 2024 Proxy Statement | | |
(c) | subject to any conditions or limitations established by the Committee, the Company’s withholding of Shares from the Option having an aggregate Fair Market Value at the time of exercise equal to the total Exercise Price pursuant to a net exercise arrangement (it being understood that, solely for purposes of determining the number of treasury shares held by the Company, the shares so withheld will not be treated as issued and acquired by the Company upon such exercise); |
(d) | to the extent permitted by law, in any other manner then permitted by the Committee; or |
(e) | a combination of the foregoing. |
| | 2024 Proxy Statement | | | B-11 |
(a) | the SAR’s Spread; by |
(b) | the number of Shares with respect to which the SAR is exercised. |
B-12 | | | 2024 Proxy Statement | | |
| | 2024 Proxy Statement | | | B-13 |
B-14 | | | 2024 Proxy Statement | | |
(a) | The Board may supplement, amend, alter, or discontinue the Plan in its sole discretion at any time and from time to time, but no supplement, amendment, alteration, or discontinuation shall be made which would impair the rights of a Participant under the Plan or an Award theretofore granted (including, without limitation, a Participant’s rights provided for in Article XIV hereof) without the Participant’s consent, except that any supplement, amendment, alteration, or discontinuation may be made to (i) avoid a material charge or expense to the Company or an Affiliate, (ii) cause this Plan to comply with applicable law, or (iii) permit the Company or an Affiliate to claim a tax deduction under applicable law. In addition, subject to the provisions of this Section, the Board of Directors, in its sole discretion at any time and from time to time, may supplement, amend, alter, or discontinue this Plan without the approval of the Company’s stockholders so long as any such amendment or alteration does not (i) expand the types of awards eligible for grants or materially increase benefits accruing to Participants under the Plan; (ii) materially increase the number of Shares subject to the Plan (other than pursuant to Section 4.06); (iii) materially increase the maximum number of Options, SARs, Shares of Restricted Stock, Restricted Stock Units, Performance Units, Performance Shares or Shares that the Committee may award to an individual Participant under the Plan (other than pursuant to Section 4.06); (iv) materially expand the classes of persons eligible or modify the requirements for participation in the Plan; (v) delete or materially limit Sections 6.08 and 7.09 of the Plan (prohibiting the repricing of Options or SARs); or (vi) otherwise require approval by the stockholders of the Company in order to comply with applicable law, the terms of a written agreement or the rules of the New York Stock Exchange or, if the Shares are not traded on the New York Stock Exchange, the principal national securities exchange upon which the Shares are traded or quoted. The Committee may supplement, amend, alter, or discontinue the terms of any Award theretofore granted, prospectively or retroactively, on the same conditions and limitations (and exceptions to limitations) as apply to the Board under the foregoing provisions of this Section, subject to any approval or limitations the Board may impose. |
(b) | If permitted by Code Section 409A, and the regulations thereunder, without resulting in any adverse tax consequences, but subject Section 12.01(c), in case of a Participant’s termination of employment by reason of death, disability or retirement of a Participant, or in the case of a Change in Control, an unforeseeable emergency or other special circumstances, the Committee may, in its sole discretion, accelerate the exercisability of an Option or SAR, accelerate the time at which any restrictions shall lapse or remove any restrictions with respect to Shares of Restricted Stock and Restricted Stock Units, and reduce or waive any Performance Targets or related business criteria applicable to Performance Shares or Performance Units. |
(c) | Subject to Sections 6.08 and 7.09 of the Plan (prohibiting the repricing of Options or SARs), the Committee may amend the terms of any Award granted under this Plan prospectively or retroactively. Except as provided in Section 4.06 of the Plan, no amendment of an Award shall impair the rights of the Participant without his or her consent. |
| | 2024 Proxy Statement | | | B-15 |
(a) | Cash Distributions. The Committee shall cause the Company to require any withholding tax obligation arising in connection with a cash distribution (or the cash portion of a distribution), up to the minimum required federal, state and local withholding taxes, including payroll taxes, to be satisfied in whole or in part, with or without the consent of the Participant or his or her beneficiary. |
(b) | Share Distributions. The Committee shall cause the Company to withhold from any distribution of shares (including the portion of a distribution consisting of shares) under this Plan an amount equal to the Participant’s or his or her beneficiary’s minimum tax liability arising from such distribution. The withholding amount shall be obtained pursuant to Section 13.02. The Participant or his or her beneficiary shall provide the Committee with such stock powers and additional information or documentation as may be necessary for the Committee to discharge its obligations under this Section 13.01(b). |
(a) | The Company is merged or consolidated or reorganized into or with another corporation or other legal person or entity, and as a result of such merger, consolidation or reorganization, less than a majority of the combined voting power of the then-outstanding securities of such corporation, person or entity immediately after such transaction are held in the aggregate by the holders of the then-outstanding securities entitled to vote generally in the election of directors (the “Voting Stock”) immediately prior to such transaction; |
B-16 | | | 2024 Proxy Statement | | |
(b) | The Company sells or otherwise transfers all or substantially all of its assets to any other corporation or other legal person or entity, and less than a majority of the combined voting power of the then-outstanding securities of such corporation, person or entity immediately after such sale or transfer is held in the aggregate by the holders of Voting Stock immediately prior to such sale or transfer; |
(c) | Any person (as the term “person” is used in Section 13(d)(3) or Section 14(d)(2) of the Exchange Act) becomes the beneficial owner (as the term “beneficial owner” is defined under SEC Rule 13d-3 or any successor rule or regulation promulgated under the Exchange Act) of securities representing twenty-five percent (25%) or more of the total votes relating to the then-outstanding securities entitled to vote generally in the election of directors (the “Voting Power”); or |
(d) | During any period of two (2) consecutive years, individuals who, at the beginning of any such period constitute the Directors, cease, for any reason, to constitute at least a majority thereof, unless the nomination for election by the Company’s stockholders of each new Director was approved by a vote of at least two-thirds (2/3) of the Directors then in office who were Directors at the beginning of any such period. |
(a) | Upon the occurrence of a Change in Control in which the Company remains the surviving entity, any Award granted under this Plan prior to the Change in Control shall continue to vest and become exercisable in accordance with the terms of its original Award Agreement unless, during the two-year period commencing on the date of the Change in Control: |
(i) | the Participant’s employment or service is involuntarily Terminated by the Company for reasons other than for Cause; or |
(ii) | the Participant Terminates his or her employment or service for Good Reason. |
(b) | If a Participant’s employment or service is Terminated as described in Section 14.02(a) above, (i) any outstanding Stock Options and SARs shall become fully vested and remain exercisable until the earlier of (A) the end of the original term of the Stock Option or SAR or (B) the second anniversary of the date the Termination occurs; provided that, if the Award Agreement provides for a longer period of exercisability following a Termination, then this clause (B) shall be the end of such longer period; (ii) any restrictions that apply to Awards made to such Participant pursuant to this Plan shall lapse; and (iii) Awards made to such Participant pursuant to this Plan that are subject to Performance Measures shall immediately be earned or vest and shall, to the extent permitted under Code Section 409A without resulting in adverse tax effects to the Participant, become immediately payable in accordance with their terms as if all of the Performance Measures had been achieved at their target levels as of the date of Termination; provided, that any Participant who Terminates his or her employment or service for Good Reason must: |
(i) | provide the Company with a written notice of his or her intent to Terminate employment or service for Good Reason within sixty (60) days after the Participant becomes aware of the circumstances giving rise to Good Reason; and |
(ii) | allow the Company thirty (30) days to remedy such circumstances to the extent curable. |
| | 2024 Proxy Statement | | | B-17 |
(a) | Upon the occurrence of a Change in Control in which the Company does not remain the surviving entity, any Awards made under this Plan shall become fully vested and exercisable on the date of the Change in Control or shall immediately vest and become immediately payable (subject to Section 14.03(e)) in accordance with their terms as if all of the Performance Measures had been achieved at their target levels as of the date of the Change in Control, and any restrictions that apply to such Awards shall lapse, and the following provisions of this Section 14.03 shall apply. |
(b) | For each Stock Option and SAR, the Participant shall receive a payment equal to the difference between the consideration (consisting of cash or other property (including securities of a successor or parent corporation)) received by holders of Shares in the Change in Control transaction and the exercise price of the applicable Stock Option or SAR, if such difference is positive. Such payment shall be made in the same form as the consideration received by holders of Shares. Any Stock Options or SARs with an exercise price that is higher than the per share consideration received by holders of Shares in connection with the Change in Control shall be cancelled for no additional consideration. |
(c) | The Participant shall receive the consideration (consisting of cash or other property (including securities of a successor or parent corporation)) that such Participant would have received in the Change in Control transaction had he or she been, immediately prior to such transaction, a holder of the number of Shares equal to the number of Restricted Stock Units and/or Shares of Restricted Stock covered by the Award and the number of Shares payable under Section 14.03(a) for Awards subject to Performance Measures. |
(d) | The payments contemplated by Sections 14.03(b) and (c) shall be made at the same time as consideration is paid to the holders of Shares in connection with the Change in Control. |
(e) | Notwithstanding anything to the contrary in this Plan, if the payment or benefit constitutes a deferral of compensation under Code Section 409A, then to the extent necessary to comply with Code Section 409A, payment or delivery shall be made on the date of payment or delivery originally provided for such payment or benefit. |
B-18 | | | 2024 Proxy Statement | | |
(a) | Limited Transfers of Nonqualified Stock Options. Notwithstanding the foregoing, the Committee may, in its sole discretion, permit the transfer of Nonqualified Stock Options by a Participant to: (i) the Participant’s spouse, any children or lineal descendants of the Participant or the Participant’s spouse, or the spouse(s) of any such children or lineal descendants (“Immediate Family Members”), (ii) a trust or trusts for the exclusive benefit of Immediate Family Members, or (iii) a partnership or limited liability company or other entity in which the Participant and/or the Immediate Family Members are the only equity owners, (collectively, “Eligible Transferees”); provided, however, that, if the Committee permits the transfer of Nonqualified Stock Options granted to the Participant, the Committee may subsequently, in its sole discretion, amend, modify, revoke, or restrict, without the prior consent, authorization, or agreement of the Eligible Transferee, the ability of the Participant to transfer Nonqualified Stock Options that have not been already transferred to an Eligible Transferee. An Option that is transferred to an Immediate Family Member shall not be transferable by such Immediate Family Member, except for any transfer by such Immediate Family Member’s will or by the laws of descent and distribution upon the death of such Immediate Family Member. Incentive Stock Options granted shall not be transferable pursuant to this Subsection. |
(b) | Exercise by Eligible Transferees. If the Committee, in its sole discretion, permits the transfer of Nonqualified Stock Options by a Participant to an Eligible Transferee under Subsection (a), the Options transferred to the Eligible Transferee must be exercised by such Eligible Transferee and, in the event of the death of such Eligible Transferee, by such Eligible Transferee’s executor, administrator or authorized representative only in the same manner, to the same extent, and under the same circumstances (including, but not limited to, the time period within which the Options must be exercised) as the Participant could have exercised such Options. The Participant, or in the event of his or her death, the Participant’s estate, shall remain liable for all federal, state, local, and other taxes applicable upon the exercise of a Nonqualified Stock Option by an Eligible Transferee. |
| | 2024 Proxy Statement | | | B-19 |
(a) | To the extent applicable, it is intended that the Plan and any grants made hereunder comply with (or be exempt from) the provisions of Code Section 409A, so that the income inclusion provisions of Section 409A(a)(1) of the Code do not apply to the Participants. This Plan and any grants made hereunder will be administered in a manner consistent with this intent. Any reference in this Plan to Code Section 409A will also include any regulations or any other formal guidance promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service. |
(b) | Neither a Participant nor any of a Participant’s creditors or beneficiaries will have the right to subject any deferred compensation (within the meaning of Code Section 409A) payable under this Plan and grants hereunder to any anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, attachment, or garnishment. Except as permitted under Code Section 409A, any deferred compensation (within the meaning of Code Section 409A) payable to a Participant or for a Participant’s benefit under this Plan and grants hereunder may not be reduced by, or offset against, any amount owing by a Participant to the Company or any of its Affiliates or Subsidiaries. |
(c) | If, at the time of a Participant’s separation from service (within the meaning of Code Section 409A), (i) the Participant is a specified employee (within the meaning of Code Section 409A and using the identification methodology selected by the Company from time to time) and (ii) the Company makes a good faith determination that an amount payable hereunder constitutes deferred compensation (within the meaning of Code Section 409A) the payment of which is required to be delayed pursuant to the six-month delay rule set forth in Code Section 409A in order to avoid taxes or penalties under Code Section 409A, then the Company will not pay such amount on the otherwise scheduled payment date but will instead pay it on the tenth business day of the seventh month after such separation from service. |
(d) | Notwithstanding any provision of the Plan and grants hereunder to the contrary, in light of the uncertainty with respect to the proper application of Code Section 409A, the Company reserves the right to make amendments to this Plan and grants hereunder as the Company deems necessary or desirable to avoid the imposition of taxes or penalties under Code Section 409A. In any case, a Participant will be solely responsible and liable for the satisfaction of all taxes and penalties that may be imposed on a Participant or for a Participant’s account in connection with this Plan and grants hereunder (including any taxes and penalties under Code Section 409A), and neither the Company nor any of its affiliates will have any obligation to provide the Participant with any tax gross-up or indemnify or otherwise hold a Participant harmless from any or all of such taxes or penalties. |
B-20 | | | 2024 Proxy Statement | | |
| | 2024 Proxy Statement | | | B-21 |